<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2022.792949</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Fructose Intake, Hypertension and Cardiometabolic Risk Factors in Children and Adolescents: From Pathophysiology to Clinical Aspects. A Narrative Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Giussani</surname> <given-names>Marco</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lieti</surname> <given-names>Giulia</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1518855/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Orlando</surname> <given-names>Antonina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/554251/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Parati</surname> <given-names>Gianfranco</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/597291/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Genovesi</surname> <given-names>Simonetta</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/552031/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Cardiologic Unit, Istituto Auxologico Italiano, Istituto Ricovero Cura Carattere Scientifico (IRCCS)</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Medicine and Surgery, University of Milano-Bicocca</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Danijela Gasevic, Monash University, Australia</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Andreas Stomby, Link&#x000F6;ping University, Sweden; Peige Song, Zhejiang University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Simonetta Genovesi <email>simonetta.genovesi&#x00040;unimib.it</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Family Medicine and Primary Care, a section of the journal Frontiers in Medicine</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>792949</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Giussani, Lieti, Orlando, Parati and Genovesi.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Giussani, Lieti, Orlando, Parati and Genovesi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Arterial hypertension, dyslipidemia, alterations in glucose metabolism and fatty liver, either alone or in association, are frequently observed in obese children and may seriously jeopardize their health. For obesity to develop, an excessive intake of energy-bearing macronutrients is required; however, ample evidence suggests that fructose may promote the development of obesity and/or metabolic alterations, independently of its energy intake. Fructose consumption is particularly high among children, because they do not have the perception, and more importantly, neither do their parents, that high fructose intake is potentially dangerous. In fact, while this sugar is erroneously viewed favorably as a natural nutrient, its excessive intake can actually cause adverse cardio-metabolic alterations. Fructose induces the release of pro-inflammatory cytokines, and reduces the production of anti-atherosclerotic cytokines, such as adiponectin. Furthermore, by interacting with hunger and satiety control systems, particularly by inducing leptin resistance, it leads to increased caloric intake. Fructose, directly or through its metabolites, promotes the development of obesity, arterial hypertension, dyslipidemia, glucose intolerance and fatty liver. This review aims to highlight the mechanisms by which the early and excessive consumption of fructose may contribute to the development of a variety of cardiometabolic risk factors in children, thus representing a potential danger to their health. It will also describe the main clinical trials performed in children and adolescents that have evaluated the clinical effects of excessive intake of fructose-containing drinks and food, with particular attention to the effects on blood pressure. Finally, we will discuss the effectiveness of measures that can be taken to reduce the intake of this sugar.</p>
</abstract>
<kwd-group>
<kwd>children</kwd>
<kwd>fructose</kwd>
<kwd>hypertension</kwd>
<kwd>cardio-metabolic risk factors</kwd>
<kwd>obesity</kwd>
<kwd>sugar-sweetened beverages</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="191"/>
<page-count count="19"/>
<word-count count="16339"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The younger generations are increasingly subjected to early and significant exposure to sugar, and fructose in particular (<xref ref-type="bibr" rid="B1">1</xref>). Fructose is associated with the development of obesity (<xref ref-type="bibr" rid="B2">2</xref>), high blood pressure (<xref ref-type="bibr" rid="B3">3</xref>) and of the metabolic syndrome (<xref ref-type="bibr" rid="B4">4</xref>), factors that increase the risk of developing cardiovascular disease in adulthood, the leading cause of death in the world (<xref ref-type="bibr" rid="B5">5</xref>). Although in children there is no precise definition of metabolic syndrome due to the lack of agreement of scientific societies on the cut off values of individual parameters, it is accepted that, even in childhood and adolescence, obesity is frequently associated with excess visceral adiposity, glucose metabolism disorders, increased blood pressure (BP) and triglycerides and decreased HDL cholesterol. It is believed that hyperinsulinism is the pathogenic mechanism underlying these alterations. Fatty liver is also frequently observed (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Generally, for developing excess weight it is necessary that the intake of calories exceeds the energy expenditure. Fructose, however, could have an additional role in the development of obesity and cardiometabolic alterations independent from the energy provided by the nutrient itself. In fact, fructose may induce metabolic alterations by stimulating the production of some substances such as uric acid, lactate, methylglyoxal, ceramide. In addition, compared to other sugars, it induces a much greater production of triglycerides and free fatty acids (FFA) leading to energy imbalance (<xref ref-type="bibr" rid="B8">8</xref>). Fructose also promotes a state of chronic inflammation through the release of pro-inflammatory cytokines, while it blocks others with a protective effect, such as adiponectin. Moreover, its interaction with the control systems of hunger and satiety, through the establishment of leptin resistance, induces an increase in caloric intake. Finally, fructose has been found to stimulate the secretion of vasopressin (<xref ref-type="bibr" rid="B8">8</xref>). The knowledge of these specific effects of fructose should direct physicians toward using preventive strategies aimed at limiting its consumption, especially in childhood. Newborn children already show an innate predilection for the sweet taste and fructose is the natural substance that arouses this sensation the most (<xref ref-type="bibr" rid="B9">9</xref>). In the light of new findings on the metabolic role of fructose, the current high consumption of free sugars, especially by children and adolescents, should be of great concern. This review will specifically focus on the changes in clinical variables associated with fructose consumption and the role of fructose in the early development of cardiometabolic risk factors, with the aim of increasing the awareness of these changes in the medical community, particularly pediatricians, and all health care providers dealing with children.</p>
</sec>
<sec id="s2">
<title>Sources of Fructose</title>
<p>The term &#x0201C;simple sugars&#x0201D; refers to the monosaccharides glucose, fructose and galactose and the disaccharides sucrose, lactose and maltose. From a nutritional point of view, the definition suggested by the World Health Organization (WHO) of &#x0201C;free sugars&#x0201D; excludes intrinsic sugars present in foods, such as lactose in milk and fructose in fruits, whereas it includes sugars added during the industrial or home preparation of foods and beverages. Free sugars also include those contained in honey, fruit juices and nectars (<xref ref-type="bibr" rid="B10">10</xref>). The free sugars that are present in food are glucose, fructose and sucrose. The sucrose molecule is composed of glucose and fructose and is broken down in the intestinal lumen by the disaccharidase enzyme. For this reason, the free sugars absorbed by the intestine are glucose and fructose. Fructose can be taken as a nutrient or it can be generated in the body through the polyol pathway which allows the transformation of glucose into fructose, through the intermediate compound sorbitol, by the enzymes aldose reductase and sorbitol dideoxygenase (<xref ref-type="bibr" rid="B11">11</xref>). This metabolic pathway, which is activated under conditions of physical or chemical stress, is especially important in some mammals that live in conditions of extreme temperature, lack of fluids and/or hypoxia, such as, for example, animals that hibernate (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). In humans, the polyol pathway is activated in para-physiological or pathological states, such as decompensated diabetes, hyperuricemia, hyperosmolarity due to dehydration or excessive salt intake, oxidative stress, hypoxia or ischemia (<xref ref-type="bibr" rid="B13">13</xref>). However, in humans and especially in children, fructose excess is virtually always due to excessive intake (<xref ref-type="bibr" rid="B14">14</xref>). Fructose is contained in fruit, but in minimal percentages compared to the weight of the fruit itself. On the other hand, fructose is present in a high concentration in honey, it represents half of the content of sucrose (the normal table sugar) and reaches 55&#x02013;60% in high fructose corn syrup (HFCS) abundantly used by the food industry, especially to sweeten soft drinks. Recently, the use of pure fructose, wrongly perceived by consumers as a natural product, has been gaining ground (<xref ref-type="table" rid="T1">Table 1</xref>). Most commercially available fructose is obtained by glucose isomerization of corn starch, with the same chemical process used to produce HFCS. Soft drinks, energy drinks, fruit juices and nectars, and generally free sugars in liquid form represent the main source of fructose consumed by children and adolescents. Even children in the first year of life can be exposed to an excessive intake of fructose, especially through the consumption of homogenized fruit. In many of these products, concentrated fruit juices made from high-fructose syrups are added. In this way it is possible to add the misleading claim &#x0201C;contains only fruit sugars&#x0201D; on the label.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Dietary sources and endogenous production of fructose.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Dietary sources (fructose content)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Fruit (depending on ripening degree): Oranges (3.2%), bananas (5.2%), strawberries (2.3%), tangerines (2.8%), apples (8%), pears (6%), lemon (0.9%) Vegetables: Carrots (2.3%), lettuce (0.3%), eggplant (1.4%), bell peppers (1.5%), peas (0.5%), tomatoes (1.7%), zucchini (1%),</td>
</tr>
<tr>
<td valign="top" align="left">Honey (40%)</td>
</tr>
<tr>
<td valign="top" align="left">Sucrose (50%)</td>
</tr>
<tr>
<td valign="top" align="left">High Fructose Corn Syrup (55%, industrial production of sugar-sweetened beverages, cakes, baked goods, pastries, catch-up sauces)</td>
</tr>
<tr>
<td valign="top" align="left">Concentrated juice, e.g., some homogenized fruits (over 60%)</td>
</tr>
<tr>
<td valign="top" align="left">Fructose as sweetener (100%)</td>
</tr>
<tr>
<td valign="top" align="left">Fruit juice, palm sugar, maple syrup (variable amounts)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Main conditions for endogenous fructose production from glucose through activation of the polyol pathway [ref. (<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>)]</bold></td>
</tr>
<tr>
<td valign="top" align="left">Hyperglycaemia (decompensated diabetes mellitus)</td>
</tr>
<tr>
<td valign="top" align="left">Hyperuricemia</td>
</tr>
<tr>
<td valign="top" align="left">Heat stress</td>
</tr>
<tr>
<td valign="top" align="left">Oxidative stress</td>
</tr>
<tr>
<td valign="top" align="left">Hyperosmolarity (dehydration or dietary high salt content)</td>
</tr>
<tr>
<td valign="top" align="left">Hypoxia</td>
</tr>
<tr>
<td valign="top" align="left">Ischemia</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3">
<title>Consumption of Free Sugars and Fructose</title>
<p>At the end of the 1700s, per capita sugar consumption in the English population was about 2 kg per year, and throughout the 1800s it did not increase much. Subsequently there was a dramatic increase in the use of this nutrient, reaching about 70 kg/year in 2000 in the US. Parallel to this phenomenon the prevalence of obesity and type 2 diabetes increased dramatically (<xref ref-type="bibr" rid="B14">14</xref>). As already mentioned, the greatest contribution to the excess of free sugars in the diet is accounted for by beverages that are sweetened with high-fructose syrups (<xref ref-type="bibr" rid="B15">15</xref>). It has been estimated that in the year 2000 the consumption of sugar-sweetened beverages (SSBs) in the US was 500 ml per person per day, about 190 liters per year, with a 5-fold increase from the 1950s to 2000 (<xref ref-type="bibr" rid="B16">16</xref>). In children, the introduction of free sugars into the diet starts very early, reaching high levels already in the first 3 years of life (<xref ref-type="bibr" rid="B17">17</xref>). However, pre-adolescence and adolescence are characterized by the highest consumption of free sugars (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Even in this age group, the greatest contribution to the intake of free sugars is given by the consumption of sugar-sweetened beverages. In fact, for many children, the limit of 10% of daily calories from simple sugars recommended by the WHO is exceeded solely by the consumption of SSBs (<xref ref-type="bibr" rid="B20">20</xref>). Available data are not sufficient to evaluate the exact amount of fructose, by disaggregating it from the total amount of sugars consumed, but it is reasonable to think that fructose constitutes at least 50% of the total intake of free sugars. Some information is provided by two American surveys carried out at a certain distance of time, the first referring to the years 1977&#x02013;1978 (<xref ref-type="bibr" rid="B21">21</xref>) and the second considering the years 1999&#x02013;2004 (<xref ref-type="bibr" rid="B14">14</xref>). When comparing these two surveys it can be seen that, in the time lapse between the two surveys, the consumption of fructose naturally present in food (mainly in fruit) has undergone a sharp decrease, while the consumption of added fructose tripled for all age groups. In childhood and adolescence, fructose consumption is much higher than in adulthood. In fact, the average consumption of added fructose in male teenagers is 68 g per day, about twice that of adults (<xref ref-type="bibr" rid="B14">14</xref>).</p>
</sec>
<sec id="s4">
<title>Fructose Metabolism</title>
<p>The glucose transporter 5 (GLUT5) allows the uptake of dietary fructose through the brush border of the enterocyte, while the glucose transporter 2 (GLUT2) promotes its release from the basal pole of the cell into the systemic circulation, toward the portal vein (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). The liver is the key organ for fructose metabolism. In fact, about 80% of dietary fructose is readily absorbed by the liver and only a small portion reaches other tissues (<xref ref-type="bibr" rid="B22">22</xref>). In addition to hepatocytes, only enterocytes, renal tubule cells and some cells of the central nervous system possess the enzymes necessary for the metabolization of fructose and the utilization of its metabolites (<xref ref-type="bibr" rid="B24">24</xref>). In contrast to glycemia, which increases strongly after meals intake and needs a long time to return to pre-prandial levels, fructosemia increases only slightly even after meals that are rich in free sugars, because the shift of fructose from the portal vein to the liver is very rapid. In addition, in the hepatocyte the metabolic pathways of fructose are uncontrolled, whereas glucose has a metabolism that is carefully regulated by mechanisms that depend on the energy level of the cell and the need to maintain glycemia in a normal range (<xref ref-type="bibr" rid="B25">25</xref>). The uncontrolled entry of fructose into the hepatocyte is a crucial point for the establishment of metabolic alterations that accompany an excessive and time-concentrated intake of this nutrient (<xref ref-type="fig" rid="F1">Figure 1</xref>). In the hepatocyte, fructose is processed by the enzyme phosphofructokinase with adenosine trisphosphate (ATP) consumption. Excessive fructose intake therefore leads to a decrease in the energy level of the cell. Moreover, the degradation of ATP produces inosine monophosphate from which uric acid is formed. Uric acid on the one hand stimulates phosphofructokinase, and on the other hand flows into the circulatory system. Once phosphorylated, fructose is broken by the enzyme aldolase into two trioses: glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. From the first compound pyruvate is generated, which is partially transformed into lactate that leaves the hepatocyte, passes into the systemic circulation and makes the uptake of glucose by muscle cells more difficult, thus increasing insulin resistance (<xref ref-type="bibr" rid="B26">26</xref>). Pyruvate also gives rise to the formation of acetylCoA that, in the presence of high levels of fructose and uric acid, tends to be involved in fatty acid production, rather than being used in mitochondria to produce energy. In case of an excessive intake of fructose there is an increased production of FFA that, when secreted as FFA, contribute to induce insulin resistance, while, when combined with glycerol, are excreted by the liver as triglycerides. After a high-fructose meal, therefore, both uricemia and triglyceridemia increase (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). In addition, some of the fatty acids produced may remain in the hepatocyte and contribute to the development of fatty liver (<xref ref-type="bibr" rid="B29">29</xref>). A side product of the synthesis of fatty acids, in particular of palmitic acid, is ceramide, which also favors the establishment of insulin resistance (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Another important alteration induced by a high level of fructose is the production of methylglyoxal derived from dihydroxyacetone phosphate (<xref ref-type="bibr" rid="B32">32</xref>&#x02013;<xref ref-type="bibr" rid="B34">34</xref>). Methylglyoxal is partly detoxified through the production of lactate, but it also has the effect of further reducing the passage of acetylCoA into the mitochondria. Thus, energy production tends to favor extra-mitochondrial anaerobic mechanisms over mitochondrial aerobic ones. Methylglyoxal also has an inhibitory action on the enzyme adenosine monophosphate kinase (AMPK). Inhibition of AMPK by methylglyoxal promotes a reduction in energy-producing catabolic pathways, such as glycolysis and fatty acid beta-oxidation, while activating energy-consuming anabolic pathways such as gluconeogenesis, cholesterol and fatty acid synthesis with release of glucose and very low-density lipoprotein cholesterol (VLDL) into the circulation. The release of fructose-derived glucose into the bloodstream via gluconeogenesis results in an increased demand for insulin. The energy intake accounted for by fructose is only slightly lower than that of glucose (<xref ref-type="bibr" rid="B25">25</xref>); fructose, however, cannot directly be used for energy purposes, but it can only indirectly through its transformation into glucose, fatty acids, and lactate with the production of a series of metabolites with potential negative effects. Overall, it can be considered that at the hepatic level about 50% of fructose is transformed into glucose, 15&#x02013;20% into glycogen, 15&#x02013;25% into lactic acid and the remainder into triglycerides, secreted as VLDL or stored in the liver (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Fructose metabolism. AMP, adenosine monophosphate; ADP, adenosine diphosphate; ATP, adenosine trisphosphate; CO<sub>2</sub>, Carbon Dioxide.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-792949-g0001.tif"/>
</fig>
</sec>
<sec id="s5">
<title>Role of Fructose in the Evolution</title>
<p>When studying the role of fructose in nutrition it is important to consider the different environmental conditions that have occurred during evolution. One of the evolutionary advantages is represented by the capacity to use the fructose present in fruits and, in smaller amounts, in vegetables, as an energy substrate. The predilection and receptors for sweet taste may have evolved to favor the use of sugars for energy production in herbivorous and omnivorous animals, but not in carnivorous ones. In addition to the use of fructose as an energy source, another evolutionary advantage has also been hypothesized. Fructose may be a kind of trigger activator of metabolic changes that may be advantageous in particular environmental conditions, such as climate change, famine, drought, conditions which only some species were able to overcome thanks to the ability to adapt, directing the metabolism to save resources and energy (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Bears, for example, prepare for hibernation by consuming ripe fruit and honey, thus taking a large amount of fructose that, directly or through its metabolites, activates a series of metabolic changes to ensure their survival during hibernation: the storage of fat and glycogen, the maintenance of a level of blood sugar and BP sufficient for vital functions and the decrease of oxygen consumption (<xref ref-type="bibr" rid="B37">37</xref>). During hibernation, the oxidation of stored fatty acids and glycogen by fructose supply is also an important source of metabolic water. Such metabolic changes, that are certainly useful to hibernating animals, can lead to a series of negative consequences if they occur in a completely different environmental situation, such as the current one of our species. Today, the majority of humanity lives in a non-hostile environment, which requires less energy expenditure and has many food resources available (<xref ref-type="bibr" rid="B38">38</xref>). In this context, the consumption of sugar, and in particular fructose, on the one hand stimulates the organism to save energy and resources, whereas on the other hand contributes to an excessive caloric intake. Thus, the metabolic changes induced by fructose that in the past helped our species to survive environmental stress, today favor the current epidemic of obesity and related diseases. In this scenario, some additional considerations must be made concerning uric acid (<xref ref-type="bibr" rid="B39">39</xref>). In almost all animal species uric acid is an intermediate metabolite of the purine catabolism, which is degraded by the enzyme uricase to allantoin, a water-soluble substance that is easily eliminated by the kidney. Only in humans and higher apes uric acid is present in biological fluids, because these species have lost the activity of the uricase enzyme (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Because increased uric acid has been described to be a risk factor for hypertension and mortality from cardiovascular causes (<xref ref-type="bibr" rid="B42">42</xref>), it seems odd that this particular mutation was selected and transmitted during evolution (<xref ref-type="bibr" rid="B43">43</xref>). However, in our ancestors a higher level in uricemia probably had favorable effects. In fact, somewhat higher values of blood glucose and BP were useful for fight or flight, while increased insulinemia favored fat storage that could be useful in times of low food availability. Finally, uric acid may also have had positive effects on brain function and immunity (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Thus, fructose, through the production of uric acid, may have aided the survival of species that had lost uricase activity. However, this mechanism is now probably negative in our current environmental situation, inducing an increase in the prevalence of obesity and non-communicable diseases. <xref ref-type="fig" rid="F2">Figure 2</xref> shows the positive and negative effects of endogenous and dietary fructose and the mechanisms by which these are mediated. <xref ref-type="table" rid="T2">Table 2</xref> summarizes the main effects of a high fructose dietary intake on the most important organs.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Effects of endogenous and dietary fructose. AMPK, Adenosine monophosphate kinase; NO, nitric oxide. Modified from Johnson et al. (<xref ref-type="bibr" rid="B13">13</xref>).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-792949-g0002.tif"/>
</fig>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Effects of a high fructose dietary intake on major organs.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Organs</bold></th>
<th valign="top" align="center"><bold>Mediators</bold></th>
<th valign="top" align="left"><bold>Metabolic effects</bold></th>
<th valign="top" align="left"><bold>Clinical manifestation</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Adipose tissue</td>
<td valign="top" align="center">FFA UA</td>
<td valign="top" align="left">&#x02191;ROS &#x02191;Inflammatory cytokines<break/>&#x02191;FFA uptake &#x02191;Lipid accumulation<break/>&#x02191;Adiponectin secretion<break/>&#x02191;Autophagy<break/>&#x02193;Insulin sensitivity&#x02193;Glucose uptake<break/>&#x02193;Leptin sensitivity<break/>&#x02193;Oxygen availability</td>
<td valign="top" align="left">Inflammation Endothelial dysfunction</td>
</tr>
<tr>
<td valign="top" align="left">Brain</td>
<td valign="top" align="center">FFA UA MG</td>
<td valign="top" align="left">&#x02191;ROS &#x02191;Inflammation cytokine<break/>&#x02193;Insulin sensitivity &#x02193;Leptin sensitivity<break/>&#x02191;Food intake</td>
<td valign="top" align="left">Increase of appetite Psychological stress</td>
</tr>
<tr>
<td valign="top" align="left">Heart/vessels</td>
<td valign="top" align="center">FFA UA</td>
<td valign="top" align="left">&#x02191;ROS<break/>&#x02191; FFA uptake<break/>&#x02191;Vascular tone &#x02193;Vascular vasodilation<break/>&#x02191;Blood pressure<break/>&#x02193;Insulin sensitivity &#x02193;Glucose consumption &#x02191;Advanced glycation end products</td>
<td valign="top" align="left">Plaque formation Hypertrophy Endothelial dysfunction Vascular stiffness</td>
</tr>
<tr>
<td valign="top" align="left">Intestine</td>
<td valign="top" align="center">UA</td>
<td valign="top" align="left">&#x02191;Endotoxins &#x02191;Bacterial composition disturbance<break/>&#x02191;Dysregulation of tight junction protein<break/>&#x02193;Insulin sensitivity</td>
<td valign="top" align="left">Increased intestinal permeability</td>
</tr>
<tr>
<td valign="top" align="left">Kidney</td>
<td valign="top" align="center">UA MG</td>
<td valign="top" align="left">&#x02191;ROS &#x02191;Inflammatory cytokines<break/>&#x02191;Dysregulation of renal organic ion transporters &#x02191;Urine sodium retention &#x02191;NO production<break/>&#x02193;Insulin sensitivity<break/>&#x02193;UA clearance</td>
<td valign="top" align="left">CKD Endothelial dysfunction</td>
</tr>
<tr>
<td valign="top" align="left">Liver</td>
<td valign="top" align="center">Lactate FFA Ceramide UA MG</td>
<td valign="top" align="left">&#x02191;Gluconeogenesis &#x02191;Glucose export<break/>&#x02191;<italic>De novo</italic> lipogenesis<break/>&#x02191;ROS &#x02191;Inflammatory cytokines<break/>&#x02191;Lipid accumulation &#x02191;VLDL-secretion &#x02191;Mitochondrial dysfunction<break/>&#x02193;Insulin sensitivity &#x02193;Glucose consumption &#x02193;Glucose uptake<break/>&#x02193;Oxygen availability</td>
<td valign="top" align="left">Steatosis NAFLD Fibrogenesis Endothelial dysfunction</td>
</tr>
<tr>
<td valign="top" align="left">Pancreatic islet</td>
<td valign="top" align="center">Glucose FFA UA</td>
<td valign="top" align="left">&#x02191;Inflammatory cytokines&#x02191;Apoptosis &#x02191;Endoplasmic reticulum stress<break/>&#x02193;Insulin sensitivity &#x02193;Leptin sensitivity</td>
<td valign="top" align="left">Glucose intolerance Increased &#x003B2;-cell mass Irregular insulin secretion</td>
</tr>
<tr>
<td valign="top" align="left">Skeletal muscle</td>
<td valign="top" align="center">Lactate FFA Ceramide UA</td>
<td valign="top" align="left">&#x02191;ROS &#x02191;Inflammatory cytokines<break/>&#x02191;FFA uptake<break/>&#x02191;Lipid accumulation<break/>&#x02191;Autophagy<break/>&#x02193;Insulin sensitivity &#x02193;Glucose uptake<break/>&#x02193;Oxygen availability</td>
<td valign="top" align="left">Inflammation response Endothelial dysfunction</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>CKD, Chronic Kidney Disease; FFA, free fatty acid; MG, methylglyoxal; NAFLD, non-alcoholic fatty liver disease; ROS, reactive oxygen species; UA, uric acid; VLDL, Very Low-Density Lipoprotein</italic>.</p>
<p><italic>Modified from Zhang et al. (<xref ref-type="bibr" rid="B8">8</xref>)</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s6">
<title>Fructose, Pregnancy, and Lactation</title>
<p>The term epigenetics refers to the science that studies the influence of the environment on the genetic expression, therefore on the phenotype. The human organism, from conception to the first 2 years after birth, is particularly sensitive to environmental stimuli. This period of life is called &#x0201C;The First Thousand Days&#x0201D; and the Developmental Origins of Health and Diseases (DPHaD) concept defines the programming of the metabolic and clinical fate of each individual. Epigenetic modifications affect not only the first offspring, but can also be transmitted to subsequent generations. In this context, the diet of the mother during gestation and lactation is particularly important, both quantitatively and qualitatively. In particular, the excess of free sugars and especially fructose, often present in western diets, may raise concerns. Even if further confirmations are needed, the results of some studies suggest pregnant women and nursing mothers to limit these nutrients.</p>
<p>It has long been known that fructose crosses the placenta (<xref ref-type="bibr" rid="B44">44</xref>) by diffusion (<xref ref-type="bibr" rid="B45">45</xref>), and probably also by an active transport mechanism (<xref ref-type="bibr" rid="B46">46</xref>). In addition, the feto-placental unit appears to be able to produce fructose from glucose via the polyol cycle (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Thus, fructose has a role in fetal metabolism. The intake of free sugars and fructose by pregnant women and nursing mothers is high (<xref ref-type="bibr" rid="B49">49</xref>). A diet that is rich in fruit has been associated with a decreased risk of pre-eclampsia (<xref ref-type="bibr" rid="B50">50</xref>) but, by contrast, excessive consumption of SSBs has been associated with an increased risk of pre-eclampsia and preterm delivery (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Several studies have been conducted in animal models in which varying amounts of fructose were administered during pregnancy. In some cases, the amount of dietary fructose was very high, resulting in an excessive intake of calories and limiting that of other important nutrients. This makes it difficult to interpret the results, and particularly to distinguish the direct effect of fructose from that of excess calories and the presence of other nutritional deficiencies. The studies performed in animal models have shown that, compared to control groups, high fructose intake was associated with a number of metabolic changes including: 1. insulin resistance, glucose intolerance, pregnancy diabetes and fatty liver in mothers (<xref ref-type="bibr" rid="B53">53</xref>&#x02013;<xref ref-type="bibr" rid="B55">55</xref>); 2. decreased weight and vascularization of the placenta (<xref ref-type="bibr" rid="B56">56</xref>); 3. hyperglycemia, hyperinsulinemia and hypertriglyceridemia in fetuses (<xref ref-type="bibr" rid="B55">55</xref>); and 4. reduced birth weight (<xref ref-type="bibr" rid="B57">57</xref>), increased body weight, fat mass and lipid profile in offspring (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>). In addition, a decreased sensitivity to leptin has been demonstrated in both mothers and fetuses (<xref ref-type="bibr" rid="B60">60</xref>). Regarding blood pressure, several studies show an increase in blood pressure values in adult animals born from mothers fed with high amounts of fructose during pregnancy (<xref ref-type="bibr" rid="B61">61</xref>&#x02013;<xref ref-type="bibr" rid="B63">63</xref>). Among these, the work of Seong et al. (<xref ref-type="bibr" rid="B64">64</xref>) is particularly interesting, as it does not only report an increase in systolic blood pressure and angiotensin II compared to controls in the first and second generation of mice born from mothers fed a diet with 20% fructose, but also an increase in renin and aldosterone found until the third and fourth generation, respectively.</p>
<p>Data from animal models in which fructose was administered only during lactation and not also during gestation are scarce. Alzamendi et al. (<xref ref-type="bibr" rid="B59">59</xref>) reported an increase in weight, food intake and decreased leptin sensitivity in male rats fed by mothers on 10% fructose diets. Similar effects were found in rats fed a fructose-rich formula milk (<xref ref-type="bibr" rid="B65">65</xref>). In a very interesting study by Goran et al. (<xref ref-type="bibr" rid="B66">66</xref>) the presence of fructose in human milk and in children fed exclusively with breast milk until the sixth month was analyzed. In breast milk the concentration of fructose was very low, equal to about 7 &#x003BC;g/mL, which is more than 30 times less than the concentration of glucose. Despite his low quantity, fructose is the only sugar that is associated with significant changes in the body composition of infants. Indeed, it is significantly associated with body weight, lean mass, fat mass, and bone mineral content assessed at the age of 6 months. Although the authors point out that their data are not sufficient to demonstrate a causal relationship, since it is not precisely known how sensitive such young children are to fructose, it is important to state that it would be appropriate to pay attention to the consumption of free sugars not only during gestation, but also during lactation.</p>
</sec>
<sec id="s7">
<title>Fructose and Cardiometabolic Risk Factors in Pediatric Age: Pathophysiological And Clinical Aspects</title>
<p>The analysis of the pathophysiological mechanisms that link an excessive intake of fructose to the development of arterial hypertension and other cardiometabolic risk factors is not easy for a number of reasons. First, the amount of fructose to be considered &#x0201C;excessive&#x0201D; is not well defined. Generally speaking, the consumption of fructose in fruits and vegetables should be encouraged because, thanks to the presence of other micronutrients, it is believed not to have the same negative effects as when it is taken as free sugar. The indication of the WHO not to exceed an intake of free sugars equal to 10% of daily calories is agreeable, but the specific quantity of fructose, the form in which it is taken (solid foods or beverages) and the time space in which it is taken should always be considered. Second, available data from studies in children are indirect and refer to fructose consumption in the form of SSBs or sweeteners added to foods. However, it should be emphasized that in these studies, fructose constitutes only one of the sweeteners used and is often added in association with glucose. Third, it is impossible to separate the direct effects of fructose from those of its metabolites. In children, fructose consumption is the main cause of increased uricemia. However, uric acid may also be generated by other sources, either endogenous (purine catabolism and some amino acids) or dietary (glutamate, purines, uric acid) and uricemia is influenced by genetically determined factors such as renal and intestinal excretion of uric acid. The metabolic and cardiovascular effects of uric acid should be discussed separately, however, and such an issue is not among the aims of this review. Some adverse effects of fructose on various organs and apparatuses have been reported, but a clear pathogenetic explanation has not yet been described. Finally, the various cardiometabolic risk factors influence and potentiate each other. For example, hyperinsulinism promotes the development of visceral obesity, which, in turn, promotes the establishment of insulin resistance. In the following paragraphs, we will briefly describe the relationship between fructose consumption and different cardiometabolic risk factors. A larger space is reserved for the relationship between fructose and the development of arterial hypertension, particularly in pediatric age.</p>
<sec>
<title>Obesity</title>
<p>Animal studies have provided information about the specific role of fructose in the development of obesity (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>). In addition to simply inducing calorie intake, fructose contributes to the development of excess weight through several additional mechanisms. Some of them have already been described, among which the <italic>ex novo</italic> production of fatty acids and triglycerides and the reduction of substrate oxidation at mitochondrial level. In addition, several metabolites of fructose (lactate, FFA, ceramide) contribute to the establishment of insulin resistance and the increase of insulin, in turn, promotes the deposition of adipose tissue. Fructose, through mechanisms not yet fully understood, may also be able to induce a resistance to the action of leptin on the satiety center in the brain, leading to an increase in food intake and the development of a positive caloric balance (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B69">69</xref>&#x02013;<xref ref-type="bibr" rid="B71">71</xref>). Fructose also has other actions that promote food intake, such as the inhibitory effect on the expression of YY peptide, Y neuropeptide, and propiomelanocortin, and the stimulation of cannabinoid 1 production (<xref ref-type="bibr" rid="B72">72</xref>). Finally, through mechanisms involving the development of reactive oxygen species (ROS) and activation of the renin-angiotensin system, fructose promotes the genesis of visceral white adipose tissue, while reducing thermogenesis produced by brown adipose tissue (<xref ref-type="bibr" rid="B73">73</xref>). In addition, uric acid <italic>per se</italic> promotes insulin resistance and induces a state of chronic inflammation. Many epidemiological studies have demonstrated an association between the consumption of free sugars and the development of obesity, particularly in children and adolescents. A meta-analysis of cohort studies found that a higher intake of SSBs among children was associated with a 55% higher risk of being overweight or obese compared to those with a lower intake (<xref ref-type="bibr" rid="B74">74</xref>). A study performed in a population of preschool-aged children found that the prevalence of obesity at 4.5 years of age was more than twice as high in sugar-sweetened beverage drinkers as in those who did not consume any (<xref ref-type="bibr" rid="B75">75</xref>). Children aged 3&#x02013;6 years with overweight mothers during pregnancy, consumed more SSBs (but less milk) and had higher waist circumference than peers born to mothers with normal body mass index (BMI) (<xref ref-type="bibr" rid="B76">76</xref>). It has been shown that in developed countries, lower socioeconomic classes have the highest prevalence of excess weight in pediatric age. In a low-income African-American preschool population of children aged 3&#x02013;5 years, SSB consumption correlated positively with the presence of overweight and obesity at baseline, and worsening of weight class was more pronounced in more frequently SSB users over a 2-year follow-up (<xref ref-type="bibr" rid="B77">77</xref>). A prospective Singaporean study observed that the consumption of SSBs in infants (18 months) was not associated with adiposity measures (BMI and skinfold thickness) and excess weight at 6 years of age. In contrast, in preschool children SSB intake was associated with higher body weight, skinfold thickness and risk of overweight/obesity at age 6 years (<xref ref-type="bibr" rid="B78">78</xref>). A German study suggested that higher consumption of free sugars during the first year of life does not lead to an increase in BMI values at 7 years, whereas this happens in subjects with higher free sugar intake in the second year of life (<xref ref-type="bibr" rid="B79">79</xref>). Regarding adolescents, an American study described a relationship between consumption of SSBs and increased body weight in a sample of more than 10,000 boys aged 9&#x02013;14 years. According to the authors, this would be mainly due to the additional energy intake provided by these drinks. In fact, the effect appears attenuated as calories are reduced (<xref ref-type="bibr" rid="B80">80</xref>). On the other hand, in a large population-representative birth cohort of Hong Kong Chinese children, frequency of SSB consumption at 11 or 13 years was not associated with subsequent BMI z-score or overweight (including obesity) up to 18 years, nor with waist circumference and waist to height ratio at 16&#x02013;19 years. This may be due to a much lower SSB intake of the participants of the study (<xref ref-type="bibr" rid="B81">81</xref>).</p>
</sec>
<sec>
<title>Disorders of Glucose Metabolism and Type 2 Diabetes</title>
<p>Glucose and fructose, besides contributing to caloric excess, alter the glycide metabolism through different mechanisms. Glucose determines a high glycemic load and glucotoxicity can damage pancreatic beta cells (<xref ref-type="bibr" rid="B82">82</xref>), while fructose has little effect on glycemia, but promotes the development of insulin resistance. In experimental animals, fructose has been shown to reduce insulin receptor sensitivity (<xref ref-type="bibr" rid="B83">83</xref>). Moreover, fructose contributes to the increase of FFA production by the liver (<xref ref-type="bibr" rid="B84">84</xref>). FFA appear to decrease the sensitivity of skeletal muscle to insulin (<xref ref-type="bibr" rid="B85">85</xref>). Moreover, FFA (saturated and long chain), through the production of ceramide, have a lipotoxic effect on pancreatic beta cells that in time may favor the development of diabetes (<xref ref-type="bibr" rid="B86">86</xref>), especially in genetically predisposed subjects. High levels of fructose have also been found to determine a reduction in the production of adiponectin with a consequent increase in insulin resistance (<xref ref-type="bibr" rid="B87">87</xref>). Finally, both glucose and fructose promote the glycation of proteins and amino acids with the resulting production of advanced glycation end products (AGEs) that also contribute to the development of diabetes (<xref ref-type="bibr" rid="B88">88</xref>). The progression of insulin resistance and the consequent worsening of glycemic control have a negative effect on the residual function of pancreatic beta cells and contribute to the production of AGEs (<xref ref-type="bibr" rid="B89">89</xref>). Uric acid plays a role in glucose metabolism as well, especially by contributing to insulin resistance (<xref ref-type="bibr" rid="B90">90</xref>). Between 2001 and 2017, there has been a considerable increase in the prevalence of type 2 diabetes mellitus in children and adolescents (from 0.34 in 2001 to 0.67 in 2017, per 1,000 subjects in this age group) (<xref ref-type="bibr" rid="B91">91</xref>). It is very likely that changes in the eating habits of children and particularly the increased consumption of SSBs are largely responsible for this situation. Unfortunately, no studies are available that correlate the consumption of fructose, free sugars or SSBs during childhood with the development of type 2 diabetes or other alterations in glucose metabolism in adulthood. However, results from studies in adults make this possible correlation very likely. The UK Scientific Advisory Committee on Nutrition concludes that, in adults, there is consistent evidence that consumption of SSBs is associated with an increased risk of developing type 2 diabetes (<xref ref-type="bibr" rid="B92">92</xref>). Similar conclusions are reached by two meta-analyses performed on adult populations (<xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>). Another meta-analysis in adults showed that an increase in consumption of SSBs by one serving per day was associated with a 13% greater incidence of type 2 diabetes, even after correction for excess weight (<xref ref-type="bibr" rid="B95">95</xref>). On the contrary, it has been shown that a correct diet that required the decrease/abolition of SSB consumption reduced the relative risk of developing type 2 diabetes (<xref ref-type="bibr" rid="B96">96</xref>). Finally, in a population of young women, a high glycemic index diet was shown to be correlated with the development of type 2 diabetes (<xref ref-type="bibr" rid="B97">97</xref>).</p>
</sec>
<sec>
<title>Dyslipidemia</title>
<p>Fructose is the most important lipogenic sugar and, as described before, a large proportion of dietary fructose intake is converted to lipids through <italic>ex novo</italic> synthesis of fatty acids. This process is increased in the presence of chronic fructose consumption, which not only increases intestinal reabsorption of fructose, thanks to the synthesis of GLUT5 transporters (<xref ref-type="bibr" rid="B98">98</xref>), but also induces an increase in the expression of all hepatic enzymes involved in lipid synthesis. In fact, fructose stimulates the expression of the sterol regulatory element-binding protein 1c (<xref ref-type="bibr" rid="B99">99</xref>) and of carbohydrate-responsive element-binding proteins (<xref ref-type="bibr" rid="B100">100</xref>&#x02013;<xref ref-type="bibr" rid="B102">102</xref>) that, together with other cofactors such as peroxisome proliferator-activated receptor gamma coactivator 1-beta (<xref ref-type="bibr" rid="B103">103</xref>), are the main regulators/stimulators of lipid synthesis (<xref ref-type="bibr" rid="B104">104</xref>). Since insulin regulates the synthesis of these element-binding proteins too, fructose can indirectly stimulate their expression also by increasing insulin levels through its effect on insulin resistance. Insulin excess also stimulates the secretion of ApoC-III, a substance able to decrease the activity of lipoprotein lipase and the hepatic clearance of lipoprotein remnants, with a consequent further increase in plasma levels of triglycerides and lipoprotein remnants, substances that are particularly atherogenic (<xref ref-type="bibr" rid="B105">105</xref>). Overweight children and adolescents more frequently have dyslipidemia than those of normal weight (<xref ref-type="bibr" rid="B106">106</xref>). By contributing to the development of obesity, fructose indirectly contributes to the establishment of various forms of dyslipidemia. However, a meta-analysis (<xref ref-type="bibr" rid="B107">107</xref>) has shown that in adults the increase in total cholesterol and LDL-cholesterol is determined only by the intake of very high amounts of fructose (<xref ref-type="bibr" rid="B108">108</xref>) and, according to some authors, only if associated with a simultaneous consumption of glucose or excessive caloric intake (<xref ref-type="bibr" rid="B109">109</xref>). The intake of high doses of fructose does not seem to induce any reduction in HDL-cholesterol that, together with the increase of triglycerides, is one of the characteristics of the dyslipidemia observed in the metabolic syndrome (<xref ref-type="bibr" rid="B107">107</xref>). Not many studies are available in children that associate cholesterol levels with fructose consumption. It has been described that obese children who consumed higher amounts of fructose had higher triglyceride values and lower HDL-cholesterol values than normal-weight peers, and fructose consumption correlated directly with the presence of smaller and therefore more atherogenic LDL particles (<xref ref-type="bibr" rid="B110">110</xref>). Interestingly, isocaloric fructose restriction resulted in a 46% decrease in LDL-cholesterol in obese children with metabolic syndrome (<xref ref-type="bibr" rid="B111">111</xref>). In contrast, an increase in total cholesterol was observed in severely obese children and adolescents who consumed higher amounts of fructose than a control group (<xref ref-type="bibr" rid="B112">112</xref>). In three studies performed in children and adolescents, it was observed that increased consumption of SSBs was associated with decreased HDL-cholesterol, but also with increased BMI values (<xref ref-type="bibr" rid="B113">113</xref>&#x02013;<xref ref-type="bibr" rid="B115">115</xref>). Therefore, a direct relationship between fructose intake and plasma cholesterol values in pediatric age has not yet been completely clarified. On the other hand, in young adults an increase in triglycerides and VLDL is associated with both acute and chronic fructose consumption (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>), even at relatively low doses (<xref ref-type="bibr" rid="B118">118</xref>). Regarding the hypothesis of an association between consumption of SSBs and triglycerides in pediatric age, data are conflicting: some studies show an increase in triglyceridemia in children and adolescents with higher consumption of SSBs (<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B118">118</xref>), whereas others studies do not show any significant differences (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>).</p>
</sec>
<sec>
<title>Non-alcoholic Fatty Liver Disease</title>
<p>The term NAFLD refers to a progressive combination of intrahepatic lipid accumulation (steatosis), inflammatory processes (steatohepatitis) and fibrosis (liver cirrhosis). In addition to the <italic>ex novo</italic> production of fatty acids and the decrease in their oxidation related to an excess intake of fructose, also the influx of circulating FFA and chylomicrons contributes to an increase in the intrahepatic lipid pool that accumulates and results in the development of NAFLD (<xref ref-type="bibr" rid="B121">121</xref>). Fructose consumption promotes inflammatory processes, either directly or via uric acid, by stimulating the generation of ROS and hepatotoxic glycation products. Inflammation, in turn, promotes fibrosis (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). It has been observed that subjects affected by NAFLD have an increased expression of fructokinase and fatty acid synthase and a greater tendency to ATP depletion and therefore to the production of uric acid (<xref ref-type="bibr" rid="B124">124</xref>). Non-alcoholic fatty liver disease, although often associated with excess weight, can also occur in non-obese subjects, both adults and children, who consume high amounts of fructose as free sugar (<xref ref-type="bibr" rid="B125">125</xref>). A study performed on a population of children and adolescents with weight excess and NAFLD, in which fructose consumption and serum uric acid were assessed, showed a prevalence of non-alcoholic steatohepatitis (NASH) of 37.6%. Both serum uric acid concentration and fructose consumption were independently associated with NASH and fructose consumption was independently associated with hyperuricaemia. Subjects with NASH had higher waist circumference, transaminase, triglycerides, and TNF alpha levels. Thus, dietary fructose consumption and serum uric acid levels are interrelated and independently associated with the presence of early hepatic organ damage (<xref ref-type="bibr" rid="B126">126</xref>). The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines highlight the higher prevalence of NAFLD in obese children compared with children with normal weight, but also report that not all children with NAFLD are obese. Indeed, the at-risk population suggested to be screened for NAFLD includes both obese and overweight children with cardiometabolic risk factors (insulin resistance, prediabetes, diabetes, dyslipidemia, and central adiposity) (<xref ref-type="bibr" rid="B127">127</xref>). A pilot study performed in a numerically small population of children with NAFLD, demonstrated that a low-fructose diet was able to induce an improvement in oxidized LDL levels, a marker of cardiovascular disease (<xref ref-type="bibr" rid="B128">128</xref>). Finally, 24 overweight Hispanic-American adolescent consumers of sweet drinks with hepatic steatosis were enrolled and randomized to drinking beverages that contained either fructose only or glucose only. After 4 weeks, insulin sensitivity, inflammatory status, plasma FFA, and LDL oxidation had improved in the group of patients taking the glucose-sweetened drinks. Although regression of hepatic steatosis was not observed, the study showed that reducing dietary fructose leads to an overall improvement in cardiovascular risk factors, suggesting that this sugar plays a central role in increasing cardiovascular disease risk in NAFLD patients (<xref ref-type="bibr" rid="B129">129</xref>).</p>
</sec>
<sec>
<title>Hypertension</title>
<p>Several decades ago it was already described that high fructose diets could induce experimental hypertension. Sprague Dawley rats, fed a diet in which fructose constituted more than 60% of the total caloric intake, developed systolic hypertension after 2 weeks and the same outcome was observed in dogs subjected to a similar diet (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B131">131</xref>). In both studies, the increase in blood pressure was associated with an increase in insulinemia (insulin levels) and insulin resistance. The role of insulin resistance in the development of fructose-related hypertension was confirmed by the demonstration of a reduced density of insulin receptors in skeletal muscle and liver of rats with fructose-diet hypertension (<xref ref-type="bibr" rid="B132">132</xref>). Interesting data were also obtained more recently in genetically hypertensive rats, in which a high fructose diet induced a further increase in BP values as the animal aged, associated with an increase in the levels of reactive oxygen species and lipid peroxidation in the rostral ventrolateral medulla. The study suggests the presence of an interaction between predisposing genetic factors and dietary habits in the establishment of hypertension (<xref ref-type="bibr" rid="B133">133</xref>). The autonomic nervous system and the renin angiotensin aldosterone system also appear to play a role in experimental fructose hypertension. Involvement of the two systems in fructose hypertension was demonstrated in experimental studies by showing that both sympathectomy and drugs inhibiting the renin angiotensin aldosterone system (RAAS) activity were able to reduce both insulin resistance and high BP values due to high fructose diets (<xref ref-type="bibr" rid="B134">134</xref>, <xref ref-type="bibr" rid="B135">135</xref>). Furthermore, a study performed in high fructose-fed rats showed that the establishment of hypertension was associated with an increase not only in insulin resistance, but also in urinary catecholamine excretion, alpha adrenergic receptor density, and angiotensin II content in the left ventricle. Administration of an AT1 receptor antagonist was able to reduce both catecholamine excretion and adrenergic receptors, without exerting any effect on insulin resistance (<xref ref-type="bibr" rid="B136">136</xref>). Moreover, in fructose-fed rats, treatment with an alpha-blocker drug prevented the increase in BP without affecting insulin levels and insulin sensitivity (<xref ref-type="bibr" rid="B137">137</xref>). Further evidence was recently provided by Chen et al. who demonstrated that in rats with fructose-induced hypertension, excessive fructose intake led to an increase in fructose concentration in the cerebrospinal fluid, a decrease of nitric oxide (NO) levels in the nucleus tractus solitarii and a reduction of baroreflex sensitivity. Taken together, these data suggest that fructose leads to sympathetic hyperactivity, which in turn results in the development of hypertension (<xref ref-type="bibr" rid="B138">138</xref>). A small randomized trial performed in young healthy volunteers (21&#x02013;33 years old) that evaluated cardiovascular system responses to fructose ingestion confirmed the involvement of the NTS. Fructose ingestion caused an increase in both systolic and diastolic BP and in heart rate. Spectral analysis of heart rate variability (HRV) showed that fructose ingestion also caused an initial increase in the low frequency component (LF, broadly taken as an expression of sympathetic activity) of HRV, and a subsequent reduction in the high frequency component (HF, expression of vagal activity), suggesting a significant reduction in baroceptor sensitivity (<xref ref-type="bibr" rid="B139">139</xref>). More recently, in a large sample of children aged 11/12 years, it was shown that high intake of SSBs was associated with increased values of systolic and diastolic blood pressure and with a shortening of the pre-ejection period of the cardiac cycle, considered a marker of sympathetic activity. The result was independent of the children&#x00027;s weight class (<xref ref-type="bibr" rid="B140">140</xref>). Some authors have suggested an association between fructose consumption and endothelial dysfunction. Endothelial dysfunction, which is characterized by a prevalence of vasoconstrictors over vasodilators, may determine an increase in BP values. It has been demonstrated that fructose-related hypertension (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B141">141</xref>) is associated with an inhibition of the vasodilator effect of prostacyclin and acetylcholine (<xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B143">143</xref>) and with an enhancement of the action of vasoconstrictor substances in experimental animals (<xref ref-type="bibr" rid="B144">144</xref>). A proper endothelial function is the result of the balance between the factors that promote vasodilation, NO and prostaglandins, and those that induce vasoconstriction, such as endothelin-1 (<xref ref-type="bibr" rid="B145">145</xref>). Oxidative stress and inflammation may play an important role as well (<xref ref-type="bibr" rid="B146">146</xref>). Fructose, either directly or through the action of uric acid, may interact with these processes. Nitric oxide is the most important dilating factor at the vascular level and is produced by the endothelium thanks to the catalyzing activity of the isoenzyme nitric oxide synthase (eNOS); the chemical reaction involves L-arginine and molecular oxygen and requires some cofactors, one of which is tetrahydrobiopterin (BH4). Alterations in NO production at the vascular level have been observed in several cardiovascular diseases, including hypertension (<xref ref-type="bibr" rid="B147">147</xref>). Fructose can interact with this system in several ways. Fructose-fed rats have been shown to exhibit increased activity of the enzyme L-argininase, which reduces the availability of L-arginine (<xref ref-type="bibr" rid="B148">148</xref>). In addition, an excess of fructose also has the effect of decreasing the availability of BH4 (<xref ref-type="bibr" rid="B149">149</xref>). In the absence of the substrate arginine and/or the cofactor BH4, eNOS promotes the development of superoxide anions from molecular oxygen that may interact with the same enzymes that produce BH4 (<xref ref-type="bibr" rid="B150">150</xref>). In fructose-fed rats, superoxide anions interact with other molecules and produce potent oxidants, which, in turn, impair the function of several proteins including eNOS, thus reducing the availability of NO and its vasodilator action (<xref ref-type="bibr" rid="B151">151</xref>). Over time, the reduction of eNOS activity may favor the proliferation of muscle tonic cells resulting in a non-reversible increase in vascular stiffness and BP values (<xref ref-type="bibr" rid="B152">152</xref>). Fructose-induced hyperinsulinism may also play a role in the development of arterial hypertension, either by directly reducing NOS production or by promoting the release of endothelin-1 (<xref ref-type="bibr" rid="B153">153</xref>, <xref ref-type="bibr" rid="B154">154</xref>). Experimental animals fed a fructose-rich diet have a condition of oxidative stress, with higher levels of oxidant agents and reduced availability of antioxidant agents (<xref ref-type="bibr" rid="B155">155</xref>&#x02013;<xref ref-type="bibr" rid="B157">157</xref>). Oxidative stress, in addition to decreasing NO activity, may contribute to endothelial dysfunction by increasing inflammation, tone, and by vascular remodeling (<xref ref-type="bibr" rid="B158">158</xref>). Whereas, no studies are available in children that correlate fructose as such taken <italic>per os</italic> with increased BP values, some evidence has been reported in young adult healthy volunteers (<xref ref-type="bibr" rid="B139">139</xref>). In most studies performed in populations of children and adolescents, only the relationship between general intake of free sugars, especially in liquid form as SSBs, and BP values was evaluated. From the results of these studies, it is difficult to evaluate the specific effect of fructose on BP, also because a high dietary intake of fructose generally leads to a worsening of weight status, a factor frequently associated with the presence of hypertension. For what regards the relationship between consumption of SSBs and BP, some meta-analyses, in adults (<xref ref-type="bibr" rid="B159">159</xref>, <xref ref-type="bibr" rid="B160">160</xref>) and in children (<xref ref-type="bibr" rid="B161">161</xref>) confirm the tendency of BP values to increase with increasing consumption of SSBs. All studies, from different countries around the world, show that the consumption of drinks with added sugar is worryingly widespread among both children and adolescents. Several observational studies that involved a very large number of subjects aged between the second decade of life and the end of adolescence, assessed the intake of SSBs using food history questionnaires. Overall, the studies showed higher systolic blood pressure (SBP) values in subjects who consumed more of these products, but in most cases the increase in BP was accompanied by higher values of BMI or waist circumference (<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B162">162</xref>). Only one study describes a higher prevalence of hypertension in normal-weight SSBs consumers than in overweight peers (<xref ref-type="bibr" rid="B163">163</xref>). Interesting are the results of a Brazilian study that confirms the presence of higher BP values in consumers of SSBs than in non-consumers; furthermore, this study shows that subjects that are accustomed to using low-calorie diet products show the highest BP values (<xref ref-type="bibr" rid="B164">164</xref>). A study on a large sample of Chinese boys reported an increase not only of SBP, but also of diastolic blood pressure (DBP) in heavy SSB users (<xref ref-type="bibr" rid="B115">115</xref>), while in another study the increase was observed only for SBP and in males (<xref ref-type="bibr" rid="B165">165</xref>). Not all studies confirm the finding of a positive association between hypertension and SSB consumption, however. In a Chinese study, no relationship between SSBs, obesity, and hypertension could be described (<xref ref-type="bibr" rid="B166">166</xref>), whereas in another study even an inverse relationship between SSB consumption and SBP values was observed (<xref ref-type="bibr" rid="B167">167</xref>). On the other hand, a prospective study evaluating SSB consumption in a population of 424 children and adolescents aged 6&#x02013;18 years followed for 3.6 years described an incidence of elevated BP values (&#x0003E;90th percentile) almost three times higher in the quartile of subjects with the highest consumption of SSBs compared with those with the lowest consumption (<xref ref-type="bibr" rid="B119">119</xref>). Of particular interest is a recent intervention study that confirms the close relationship between SSBs and BP. The research was conducted in 30 overweight and obese adolescent boys, all heavy users of SSBs. The sample was randomized to take SBBs or an isocaloric amount of low-fat milk for 3 weeks. The study included a cross-over phase between the two groups after a washout period. The SBP z-score and uricemia were significantly lower when milk was taken instead of SSBs (<xref ref-type="bibr" rid="B120">120</xref>). Only one study evaluated the consumption of sugars taken via solid foods (sugary snacks) and confirmed that the subjects with the highest level of consumption had an increased risk of being hypertensive. It should be noted however, that these snacks also had a high salt content (<xref ref-type="bibr" rid="B168">168</xref>). Several studies showed that high salt intake is associated with increased BP values and hypertension prevalence in the pediatric population. It is interesting to note that a significant association between SSBs and salt intake was also described in children and adolescents (<xref ref-type="bibr" rid="B169">169</xref>). <xref ref-type="table" rid="T3">Table 3</xref> shows the main available studies assessing the relationship between fructose intake and BP in pediatric age.</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Main available studies assessing the relationship between SSB intake and BP in pediatric age.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>References</bold><break/><bold>Country</bold></th>
<th valign="top" align="center"><bold>Sample size (number of subjects)</bold></th>
<th valign="top" align="center"><bold>Age range</bold></th>
<th valign="top" align="left"><bold>Study design</bold></th>
<th valign="top" align="left"><bold>Outcome</bold></th>
<th valign="top" align="left"><bold>Main results</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Nguyen et al. (<xref ref-type="bibr" rid="B162">162</xref>)<break/>US</td>
<td valign="top" align="center">4,867</td>
<td valign="top" align="center">12&#x02013;18</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP adjusted for age, race/ethnicity, sex, total calories, BMI z-score, sodium intake, smoking, and alcohol</td>
<td valign="top" align="left">Higher SSB consumption associated with higher serum uric acid (increased by 0.18 mg/dL) and SBP (increased by 0.17 z-score).</td>
</tr>
<tr>
<td valign="top" align="left">Bremer et al. (<xref ref-type="bibr" rid="B114">114</xref>)<break/>US</td>
<td valign="top" align="center">6,967</td>
<td valign="top" align="center">12&#x02013;19</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP</td>
<td valign="top" align="left">Higher SSB consumption associated with higher HOMA-Index, waist circumference, BMI and SBP (High intake vs. low intake: 111.1 vs. 107.9 mmHg, <italic>p</italic> = 0.03).</td>
</tr>
<tr>
<td valign="top" align="left">Ambrosini et al. (<xref ref-type="bibr" rid="B113">113</xref>)<break/>Australia</td>
<td valign="top" align="center">1,433</td>
<td valign="top" align="center">14&#x02013;17</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP and DBP adjusted for adjusted for age, pubertal stage, physical activity, dietary misreporting, maternal education, and family income.</td>
<td valign="top" align="left">Higher SSB consumption associated with higher SBP (highest tertile vs. lowest tertile &#x0002B;1.5 mmHg, <italic>p</italic> = 0.03) and overweight/obesity risk (OR: 4.8, 95%CI: 2.1&#x02013;11.4).</td>
</tr>
<tr>
<td valign="top" align="left">Lin et al. (<xref ref-type="bibr" rid="B165">165</xref>)<break/>Taiwan</td>
<td valign="top" align="center">2,727</td>
<td valign="top" align="center">12&#x02013;16</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP adjusted for study area, age, gender, physical activity, total calories, intake of meat, seafood, fruit, fried, food with jelly/honey, alcohol drinking, smoking.</td>
<td valign="top" align="left">Higher SSB consumption associated with higher SBP (highest SBB intake vs. no intake &#x0002B;3.47 mmHg, <italic>p</italic> = 0.004).</td>
</tr>
<tr>
<td valign="top" align="left">Mirmiran et al. (<xref ref-type="bibr" rid="B119">119</xref>)<break/>Iran</td>
<td valign="top" align="center">4,24</td>
<td valign="top" align="center">6&#x02013;18</td>
<td valign="top" align="left">Prospective study</td>
<td valign="top" align="left">Incident hypertension.</td>
<td valign="top" align="left">Higher SSB consumption associated with higher hypertension incidence (highest quartile vs. lowest quartile: OR 2.79, 95%CI 1.02&#x02013;7.64).</td>
</tr>
<tr>
<td valign="top" align="left">Asghari et al. (<xref ref-type="bibr" rid="B168">168</xref>)<break/>Iran</td>
<td valign="top" align="center">4,24</td>
<td valign="top" align="center">6&#x02013;18</td>
<td valign="top" align="left">Prospective study</td>
<td valign="top" align="left">Incident hypertension adjusted for age, sex, total energy intake, physical activity, dietary fiber, family history of diabetes, and body mass index.</td>
<td valign="top" align="left">Higher energy-dense nutrient-poor solid snack intake associated with higher incidence of hypertension (OR: 2.99, 95%CI: 1.00&#x02013;8.93).</td>
</tr>
<tr>
<td valign="top" align="left">Souza et al. (<xref ref-type="bibr" rid="B164">164</xref>)<break/>Brazil</td>
<td valign="top" align="center">488</td>
<td valign="top" align="center">9&#x02013;16</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP and DBP adjusted for sex, age, BMI, physical activity, addition of salt to food, and education of the head of the family.</td>
<td valign="top" align="left">Higher soft drink consumption associated with higher SBP/DBP (no soft drink vs. SSB vs. diet soft drink: mean SBP 99.7 vs. 101.8 vs. 105.1 mmHg, <italic>p</italic> = 0.01 and mean DBP 57.2 vs. 58.2 vs. 60.5 mmHg, <italic>p</italic> = 0.04)</td>
</tr>
<tr>
<td valign="top" align="left">Gui et al. (<xref ref-type="bibr" rid="B166">166</xref>)<break/>China</td>
<td valign="top" align="center">53,151</td>
<td valign="top" align="center">6&#x02013;17</td>
<td valign="top" align="left">National cross-sectional study</td>
<td valign="top" align="left">Prevalent hypertension adjusted for age, sex, residence, socioeconomic status, diet, screen time, and physical activity.</td>
<td valign="top" align="left">Neither general obesity nor hypertension associated with SSB consumption.</td>
</tr>
<tr>
<td valign="top" align="left">de Boer et al. (<xref ref-type="bibr" rid="B140">140</xref>)<break/>Netherlands</td>
<td valign="top" align="center">2,519 &#x0002B; 769</td>
<td valign="top" align="center">5&#x02013;6/11&#x02013;12</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP and DBP (adjusted for ethnicity, BMI, physical activity, screen time, gestational age, birth weight, maternal and paternal BMI, pubertal stage</td>
<td valign="top" align="left">Higher SSB consumption associated with higher SBP at 11&#x02013;12 age (highest tertile vs. lowest tertile: SBP &#x0002B;2.3 mmHg, <italic>p</italic> = 0.006)</td>
</tr>
<tr>
<td valign="top" align="left">Qin et al. (<xref ref-type="bibr" rid="B163">163</xref>)<break/>China</td>
<td valign="top" align="center">10,091</td>
<td valign="top" align="center">9&#x02013;12</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">Prevalent hypertension adjusted for school, parental education, physical activity, diet intake.</td>
<td valign="top" align="left">Higher SSB consumption associated with higher hypertension prevalence (overall: OR1.40, 95%CI 1.15&#x02013;1.70); normal weight: OR 1.78, 95% CI 1.20&#x02013;2.65; overweight or obese: OR 1.28, 95% CI 1.01&#x02013;1.61)</td>
</tr>
<tr>
<td valign="top" align="left">He et al. (<xref ref-type="bibr" rid="B115">115</xref>)<break/>China</td>
<td valign="top" align="center">2,032</td>
<td valign="top" align="center">7&#x02013;18</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">Prevalent hypertension.</td>
<td valign="top" align="left">SSB consumption associated with the risk of obesity (OR 2.08, 95% CI 1.21&#x02013;3.54) and hypertriglyceridemia (OR 1.70, 95%CI 1.02&#x02013;3.06), but not with a significant increase in the prevalence of hypertension.</td>
</tr>
<tr>
<td valign="top" align="left">Zhu et al. (<xref ref-type="bibr" rid="B167">167</xref>)<break/>China</td>
<td valign="top" align="center">3,958</td>
<td valign="top" align="center">6&#x02013;17</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP (adjusted for age, sex, daily energy intake, pubertal stage, sedentary time, maternal education, and household income)</td>
<td valign="top" align="left">Higher SSB consumption inversely associated with SBP values (<italic>p</italic> &#x0003C; 0.05)</td>
</tr>
<tr>
<td valign="top" align="left">Perng et al. (<xref ref-type="bibr" rid="B170">170</xref>)<break/>Mexico</td>
<td valign="top" align="center">242</td>
<td valign="top" align="center">8&#x02013;14</td>
<td valign="top" align="left">Cross-sectional study</td>
<td valign="top" align="left">SBP and DBP (adjusted for age and pubertal status)</td>
<td valign="top" align="left">Higher SSB intake associated with higher BP values (highest quartile vs. lowest quartile: SBP &#x0002B;4.65 mmHg and DBP &#x0002B;3.08 mmHg in girls, <italic>p</italic> = 0.07 and SBP &#x0002B;8.79 mmHg and DBP &#x0002B;7.1 mmHg in boys, <italic>p</italic> &#x0003C; 0.001).</td>
</tr>
<tr>
<td valign="top" align="left">Chiu et al. (<xref ref-type="bibr" rid="B120">120</xref>)<break/>US</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">13&#x02013;18</td>
<td valign="top" align="left">Two-period randomized study (SBBs vs. low fat milk for 3 weeks with crossover to the alternate beverage after a &#x02265; 2 weeks washout)</td>
<td valign="top" align="left">SBP</td>
<td valign="top" align="left">SBP z-score (0.0 vs. 0.2, <italic>p</italic> = 0.04) and serum uric acid (362 vs. 381 umol/L, <italic>p</italic> = 0.02) significantly lower after milk compared to SSBs.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; SSB, sugar-sweetened beverage</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s8">
<title>Intervention Directed at the Youth Consumption of Sugar Sweetened Beverages</title>
<p>Consumption of sweetened beverages, such as non-diet soft drinks, regular soda, iced tea, sports drinks, energy drinks, fruit punches, sweetened waters, and sweetened tea and coffee, is considered an important contributor to the widespread diffusion of obesity and its complications. As noted above, when considering studies related to the effects of excessive intake of SSBs, however, it should be emphasized that we are not referring to the intake of fructose alone, because glucose is also contained in these beverages. The evidence of the association between excessive SSBs and excess weight has raised the question of how to reduce their consumption in children and adolescents. Many scientific societies called for reducing the consumption of sugary drinks in pediatric age by fixing, in different ways, the daily quota not to be exceeded. However, it should be noted that these indications are only mediations to mitigate the current exaggerated hedonistic consumption of free sugars and do not correspond to the real needs of the human body. In fact, the daily consumption of free sugars could be equal to zero, as the need of glucose can be entirely satisfied by complex carbohydrates with low glycemic index, while a daily consumption of fruits and vegetables is sufficient to meet the need of fructose. Interventions aimed at reducing the consumption of SSBs in children include both educational interventions, carried out with the aim of improving eating habits, and environmental interventions to reduce the availability of SSBs. A typical example of the latter is the proposal of a &#x0201C;sugar tax.&#x0201D;</p>
<p>Since children spend most of their day time in school, this is an ideal setting for programs targeting healthy dietary behaviors (<xref ref-type="bibr" rid="B171">171</xref>). School-based intervention programs have been shown to yield positive results in preventing and reducing obesity (<xref ref-type="bibr" rid="B172">172</xref>). Many interventions have been performed in schools to see if educational programs with the purpose of reducing SSB consumption had an effect on body weight and the prevalence of excess weight in groups of children and adolescents (<xref ref-type="bibr" rid="B173">173</xref>). Considering only the randomized trials, altogether the results were positive, albeit with some differences. The association between consumption of SSBs and excess weight has been unequivocally demonstrated by a study performed in normal-weight children aged 5&#x02013;12 years. Participants were randomized to receive once a day 250 mL of a beverage sweetened with non-caloric substances (sugar-free group) or a beverage sweetened with sucrose that provided 104 kcal (sugar group). At the end of an 18-month follow-up, the sugar group had higher values of body weight, BMI z-score, skinfold-thickness, waist-to-height ratio, and fat mass than the sugar-free group (<xref ref-type="bibr" rid="B174">174</xref>). A trial that randomized 644 children aged 7&#x02013;14 years to receive an educational intervention resulted only in a modest reduction in SSB consumption in the intervention group compared with the control group, that was, however, associated with a significant reduction in the prevalence of excess weight (<xref ref-type="bibr" rid="B175">175</xref>).</p>
<p>A pilot study, also aimed at examining the effect of decreasing SSB consumption on body weight, did not lead to a significant reduction in BMI in the intervention group, despite the fact that in this group SSB consumption was almost completely eliminated. However, a significant reduction in BMI was observed among subjects with the highest body weight values at baseline (<xref ref-type="bibr" rid="B176">176</xref>). Another randomized trial performed in 7&#x02013;9 year old students was targeted to reduce the availability of SSBs and increase the availability of water. The trial did not impact the SSB consumption of the entire study population, however and a positive result was observed in girls only (<xref ref-type="bibr" rid="B177">177</xref>). Finally, in another study, 224 obese adolescents who were regular consumers of SSBs were randomly divided into two groups, one in which a 1-year intervention was planned, designed to decrease consumption of sugar-sweetened beverages and a control group that did not include any intervention. In the first year of follow-up, consumption of SSBs in the intervention group was significantly lower than in the control group and remained so in the second year of observation. BMI values were significantly lower in the intervention group, but this difference disappeared at the end of the second year of follow-up (<xref ref-type="bibr" rid="B178">178</xref>). In spite of these results, which emphasize the need of additional intervention studies on this issue, a systematic review by Frank Hu et al. concluded that, overall, there is enough scientific evidence to support the possibility to reduce the prevalence of excess weight in children by decreasing consumption of SSBs (<xref ref-type="bibr" rid="B179">179</xref>). The need to reduce consumption of SSBs by children and, especially, adolescents led many countries to impose taxation on these beverages to discourage their consumption (<xref ref-type="bibr" rid="B180">180</xref>). The purchase of SSBs should not be discouraged only among adolescents, but also among adults, who are role models for youth and buy most of the SSBs consumed by children (<xref ref-type="bibr" rid="B181">181</xref>). In many countries of the world the sugar tax, in different forms, has been introduced since several years (<xref ref-type="bibr" rid="B182">182</xref>). One of the first pioneer countries to introduce a sugar tax was Denmark in 1930. The United Kingdom (UK) has introduced the SSB tax in 2018. In the US taxes have been imposed mostly on sodas and were never &#x0003E;10% of the price (<xref ref-type="bibr" rid="B183">183</xref>). Increasing taxation of SSBs and subsidizing healthy drinks could impact the reduction of obesity in children and adolescents (<xref ref-type="bibr" rid="B184">184</xref>). Current findings in the literature are not very strong, but suggest potential benefits regarding dietary behaviors from the implementation of such a tax (<xref ref-type="bibr" rid="B185">185</xref>). Several studies examining the effect of taxes on young school children or adolescents found limited effects on SSB consumption or BMI (<xref ref-type="bibr" rid="B186">186</xref>&#x02013;<xref ref-type="bibr" rid="B188">188</xref>). More recent studies have provided more encouraging results. A US trial assessed if taxes could influence sweetened beverage intake in 86 928 high school students and found that the tax was associated with a statistically significant reduction in SSB consumption of 0.81 servings per week, 2 years after the implementation (<xref ref-type="bibr" rid="B189">189</xref>). A Mexican study assessed whether increasing the price of SSBs was associated with adolescent weight-related outcomes after implementation of the SSB tax. Increased prices were associated with decreased prevalence of excess weight among girls only, mostly in those with higher BMI, and where the price increment due to the tax was greater than 10% (<xref ref-type="bibr" rid="B190">190</xref>). The fact that a higher tax may be more effective has also been suggested by a qualitative study performed in a Detroit suburban middle school that gathered information on how a 20% tax on SSBs would affect adolescent SSB consumption. Most students reported that they would decrease their consumption of SSBs if a 20% tax were implemented (<xref ref-type="bibr" rid="B191">191</xref>). In conclusion, a sugar tax combined with adequate information campaigns on the health harms of SSBs and a reduction of sugar content in recipes by companies could have a significant impact for healthy eating habits in children and adolescents in the coming years. Moreover, additional studies testing the efficacy of interventions aimed at reducing fructose and free sugars intake in children and adolescents are needed.</p>
</sec>
<sec sec-type="conclusions" id="s9">
<title>Conclusions</title>
<p>Despite the fact that in recent years the attention of parents to the eating habits of their children has increased, there still may be not enough concern about the intake of free sugars and fructose, as these nutrients may be erroneously perceived as &#x0201C;natural&#x0201D; and &#x0201C;necessary&#x0201D; and are therefore proposed even to the youngest children. Free sugars, however, are not at all indispensable in a correct diet. The consumption of free sugars was introduced in our diet relatively recently, and this was possible thanks to the industrial production of sugar, at first extracted from sugar cane and subsequently from sugar beets. Starting from the seventies of the last century, the introduction of HFCS, associated to the increasing use of SSBs, has led to a significant increase in the consumption of free sugars, including fructose. Young people are the heaviest consumers of free sugars and fructose. Fructose has specific metabolic pathways and, directly or through its metabolites, may promote the development of arterial hypertension and metabolic syndrome. No epidemiological or clinical studies are available in children that specifically demonstrate the effects of fructose. In fact, first of all, fructose is practically never consumed alone and secondly, it is rapidly removed from the circulation, so it cannot be dosed properly. On the other hand, there are numerous epidemiological studies, even in children, on the association between fructose and glucose consumption introduced by drinking SSBs and the presence of cardio-metabolic risk factors. The mixture of these two carbohydrates is particularly &#x0201C;explosive&#x0201D; as fructose and glucose, each acting through different mechanisms, can contribute synergistically to the development of cardiovascular disease. Vascular alterations at the base of these pathologies start in pediatric age and it would be therefore reasonable to start in time to prevent them. Given the large increase in the consumption of foods and beverages with added fructose in recent decades by children and adolescents, it is reasonable to think that increased fructose intake currently represents a real problem for the health of the younger generations, even if specific studies on this subject have not yet been published. A limitation of the consumption of free sugars and fructose should be among the first and most important measures to be taken for an effective prevention of increased cardiovascular risk.</p>
</sec>
<sec id="s10">
<title>Author Contributions</title>
<p>SG and MG conceptualized and designed the review, drafted the initial manuscript, and reviewed and revised the manuscript. GL and AO prepared the tables and performed the reference search. GP reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>VS</given-names></name> <name><surname>Hu</surname> <given-names>FB</given-names></name></person-group>. <article-title>Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us</article-title>. <source>J Am Coll Cardiol.</source> (<year>2015</year>) <volume>66</volume>:<fpage>1615</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2015.08.025</pub-id><pub-id pub-id-type="pmid">26429086</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>VS</given-names></name> <name><surname>Schulze</surname> <given-names>MB</given-names></name> <name><surname>Hu</surname> <given-names>FB</given-names></name></person-group>. <article-title>Intake of sugar-sweetened beverages and weight gain: a systematic review</article-title>. <source>Am J Clin Nutr.</source> (<year>2006</year>) <volume>84</volume>:<fpage>274</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/84.2.274</pub-id><pub-id pub-id-type="pmid">16895873</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madero</surname> <given-names>M</given-names></name> <name><surname>Perez-Pozo</surname> <given-names>SE</given-names></name> <name><surname>Jalal</surname> <given-names>D</given-names></name> <name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>S&#x000E1;nchez-Lozada</surname> <given-names>LG</given-names></name></person-group>. <article-title>Dietary fructose and hypertension</article-title>. <source>Curr Hypertens Rep.</source> (<year>2011</year>) <volume>13</volume>:<fpage>29</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s11906-010-0163-x</pub-id><pub-id pub-id-type="pmid">20957458</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname> <given-names>GA</given-names></name></person-group>. <article-title>Fructose and risk of cardiometabolic disease</article-title>. <source>Curr Atheroscler Rep.</source> (<year>2012</year>) <volume>14</volume>:<fpage>570</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s11883-012-0276-6</pub-id><pub-id pub-id-type="pmid">22949106</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname> <given-names>S</given-names></name> <name><surname>Reddy</surname> <given-names>S</given-names></name> <name><surname>Ounpuu</surname> <given-names>S</given-names></name> <name><surname>Anand</surname> <given-names>S</given-names></name></person-group>. <article-title>Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization</article-title>. <source>Circulation.</source> (<year>2001</year>) <volume>104</volume>:<fpage>2746</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1161/hc4601.099487</pub-id><pub-id pub-id-type="pmid">11723030</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimmet</surname> <given-names>P</given-names></name> <name><surname>Alberti</surname> <given-names>G</given-names></name> <name><surname>Kaufman</surname> <given-names>F</given-names></name> <name><surname>Tajima</surname> <given-names>N</given-names></name> <name><surname>Silink</surname> <given-names>M</given-names></name> <name><surname>Arslanian</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>The metabolic syndrome in children and adolescents</article-title>. <source>Lancet (London, England).</source> (<year>2007</year>) <volume>369</volume>:<fpage>2059</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60958-1</pub-id><pub-id pub-id-type="pmid">17586288</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname> <given-names>E</given-names></name> <name><surname>Daniels</surname> <given-names>SR</given-names></name> <name><surname>Meigs</surname> <given-names>JB</given-names></name> <name><surname>Dolan</surname> <given-names>LM</given-names></name></person-group>. <article-title>Instability in the diagnosis of metabolic syndrome in adolescents</article-title>. <source>Circulation.</source> (<year>2007</year>) <volume>115</volume>:<fpage>2316</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.669994</pub-id><pub-id pub-id-type="pmid">17420347</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>DM</given-names></name> <name><surname>Jiao</surname> <given-names>RQ</given-names></name> <name><surname>Kong</surname> <given-names>LD</given-names></name></person-group>. <article-title>High dietary fructose: direct or indirect dangerous factors disturbing tissue and organ functions</article-title>. <source>Nutrients.</source> (<year>2017</year>) <volume>9</volume>:<fpage>335</fpage>. <pub-id pub-id-type="doi">10.3390/nu9040335</pub-id><pub-id pub-id-type="pmid">28353649</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mennella</surname> <given-names>JA</given-names></name></person-group>. <article-title>Ontogeny of taste preferences: basic biology and implications for health</article-title>. <source>Am J Clin Nutr.</source> (<year>2014</year>) <volume>99</volume>:<fpage>704S</fpage>&#x02212;<lpage>11S</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.113.067694</pub-id><pub-id pub-id-type="pmid">24452237</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <article-title>Guideline: sugars intake for adults and children</article-title>. In: <source>WHO Libr Cat Data</source>, <volume>Vol. 26</volume>. (<year>2015</year>). p. <fpage>34</fpage>&#x02013;<lpage>36</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK285537/">https://www.ncbi.nlm.nih.gov/books/NBK285537/</ext-link> (accessed on August 29, 2021).</citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanaspa</surname> <given-names>MA</given-names></name> <name><surname>Kuwabara</surname> <given-names>M</given-names></name> <name><surname>Andres-Hernando</surname> <given-names>A</given-names></name> <name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Cicerchi</surname> <given-names>C</given-names></name> <name><surname>Jensen</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2018</year>) <volume>115</volume>:<fpage>3138</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1713837115</pub-id><pub-id pub-id-type="pmid">30224469</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>YC</given-names></name> <name><surname>Kaneko</surname> <given-names>M</given-names></name> <name><surname>Bakr</surname> <given-names>S</given-names></name> <name><surname>Liao</surname> <given-names>H</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <name><surname>Lewis</surname> <given-names>ER</given-names></name> <etal/></person-group>. <article-title>Central role for aldose reductase pathway in myocardial ischemic injury</article-title>. <source>FASEB J.</source> (<year>2004</year>) <volume>18</volume>:<fpage>1192</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-1400com</pub-id><pub-id pub-id-type="pmid">15284219</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Stenvinkel</surname> <given-names>P</given-names></name> <name><surname>Andrews</surname> <given-names>P</given-names></name> <name><surname>S&#x000E1;nchez-Lozada</surname> <given-names>LG</given-names></name> <name><surname>Nakagawa</surname> <given-names>T</given-names></name> <name><surname>Gaucher</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughts</article-title>. <source>J Intern Med.</source> (<year>2020</year>) <volume>287</volume>:<fpage>252</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12993</pub-id><pub-id pub-id-type="pmid">31621967</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marriott</surname> <given-names>BP</given-names></name> <name><surname>Cole</surname> <given-names>N</given-names></name> <name><surname>Lee</surname> <given-names>E</given-names></name></person-group>. <article-title>National estimates of dietary fructose intake increased from 1977 to 2004 in the United States</article-title>. <source>J Nutr.</source> (<year>2009</year>) <volume>139</volume>:<fpage>1228S</fpage>&#x02212;<lpage>35S</lpage>. <pub-id pub-id-type="doi">10.3945/jn.108.098277</pub-id><pub-id pub-id-type="pmid">19403716</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Segal</surname> <given-names>MS</given-names></name> <name><surname>Sautin</surname> <given-names>Y</given-names></name> <name><surname>Nakagawa</surname> <given-names>T</given-names></name> <name><surname>Feig</surname> <given-names>DI</given-names></name> <name><surname>Kang</surname> <given-names>DH</given-names></name> <etal/></person-group>. <article-title>Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease</article-title>. <source>Am J Clin Nutr.</source> (<year>2007</year>) <volume>86</volume>:<fpage>899</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/86.4.899</pub-id><pub-id pub-id-type="pmid">17921363</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname> <given-names>GA</given-names></name></person-group>. <article-title>Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people</article-title>. <source>Adv Nutr.</source> (<year>2013</year>) <volume>4</volume>:<fpage>220</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3945/an.112.002816</pub-id><pub-id pub-id-type="pmid">23493538</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccotti</surname> <given-names>GV</given-names></name> <name><surname>Cassatella</surname> <given-names>C</given-names></name> <name><surname>Morelli</surname> <given-names>A</given-names></name> <name><surname>Cucugliato</surname> <given-names>MC</given-names></name> <name><surname>Catinello</surname> <given-names>G</given-names></name> <name><surname>del Balzo</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Nutrient intake in Italian infants and toddlers from North and South Italy: the Nutrintake 636 study</article-title>. <source>Nutrients.</source> (<year>2014</year>) <volume>6</volume>:<fpage>3169</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.3390/nu6083169</pub-id><pub-id pub-id-type="pmid">25111122</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimes</surname> <given-names>CA</given-names></name> <name><surname>Riddell</surname> <given-names>LJ</given-names></name> <name><surname>Campbell</surname> <given-names>KJ</given-names></name> <name><surname>Nowson</surname> <given-names>CA</given-names></name></person-group>. <article-title>Dietary salt intake, sugar-sweetened beverage consumption, and obesity risk</article-title>. <source>Pediatrics.</source> (<year>2013</year>) <volume>131</volume>:<fpage>14</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2012-1628</pub-id><pub-id pub-id-type="pmid">23230077</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verduci</surname> <given-names>E</given-names></name> <name><surname>Banderali</surname> <given-names>G</given-names></name> <name><surname>Montanari</surname> <given-names>C</given-names></name> <name><surname>Berni Canani</surname> <given-names>R</given-names></name> <name><surname>Cimmino Caserta</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Childhood dietary intake in Italy: the epidemiological &#x0201C;MY FOOD DIARY&#x0201D; Survey</article-title>. <source>Nutrients.</source> (<year>2019</year>) <volume>21</volume>:<fpage>1129</fpage>. <pub-id pub-id-type="doi">10.3390/nu11051129</pub-id><pub-id pub-id-type="pmid">31117214</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosinger</surname> <given-names>A</given-names></name> <name><surname>Herrick</surname> <given-names>K</given-names></name> <name><surname>Gahche</surname> <given-names>J</given-names></name> <name><surname>Park</surname> <given-names>S</given-names></name></person-group>. <article-title>Sugar-sweetened beverage consumption among U.S. Youth, 2011&#x02013;2014</article-title>. <source>NCHS Data Brief.</source> (<year>2017</year>) <volume>271</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>YK</given-names></name> <name><surname>Yetley</surname> <given-names>EA</given-names></name></person-group>. <article-title>Intakes and food sources of fructose in the United States</article-title>. <source>Am J Clin Nutr.</source> (<year>1993</year>) <volume>58</volume>(<supplement>5 Suppl</supplement>):<fpage>737S</fpage>&#x02212;<lpage>747S</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/58.5.737S</pub-id><pub-id pub-id-type="pmid">8213605</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drozdowski</surname> <given-names>LA</given-names></name> <name><surname>Thomson</surname> <given-names>AB</given-names></name></person-group>. <article-title>Intestinal sugar transport</article-title>. <source>World J Gastroenterol.</source> (<year>2006</year>) <volume>12</volume>:<fpage>1657</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v12.i11.1657</pub-id><pub-id pub-id-type="pmid">16586532</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname> <given-names>S</given-names></name> <name><surname>Fussell</surname> <given-names>SL</given-names></name> <name><surname>Singh</surname> <given-names>AK</given-names></name> <name><surname>Lucas</surname> <given-names>F</given-names></name> <name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Kim</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension</article-title>. <source>J Biol Chem.</source> (<year>2009</year>) <volume>284</volume>:<fpage>5056</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M808128200</pub-id><pub-id pub-id-type="pmid">19091748</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mortera</surname> <given-names>RR</given-names></name> <name><surname>Bains</surname> <given-names>Y</given-names></name> <name><surname>Gugliucci</surname> <given-names>A</given-names></name></person-group>. <article-title>Fructose at the crossroads of the metabolic syndrome and obesity epidemics</article-title>. <source>Front Biosci.</source> (<year>2019</year>) <volume>24</volume>:<fpage>4713</fpage>. <pub-id pub-id-type="doi">10.2741/4713</pub-id><pub-id pub-id-type="pmid">30468651</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname> <given-names>VC</given-names></name> <name><surname>Tappy</surname> <given-names>L</given-names></name></person-group>. <article-title>Physiological handling of dietary fructose-containing sugars: implications for health</article-title>. <source>Int J Obes (Lond).</source> (<year>2016</year>) <volume>40</volume>(<supplement>Suppl. 1</supplement>):<fpage>S6</fpage>&#x02013;<lpage>S11</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2016.8</pub-id><pub-id pub-id-type="pmid">27001645</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>C.S.</given-names></name> <name><surname>Kim</surname> <given-names>Y.B.</given-names></name> <name><surname>Lee</surname> <given-names>F.N.</given-names></name> <name><surname>Zabolotny</surname> <given-names>J.M.</given-names></name> <name><surname>Kahn</surname> <given-names>B.B.</given-names></name> <name><surname>Youn</surname> <given-names>H.</given-names></name> <etal/></person-group>. <article-title>Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling</article-title>. <source>Am J Physiol Endocrinol Metab.</source> (<year>2002</year>) <volume>283</volume>:<fpage>E233</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00557.2001</pub-id><pub-id pub-id-type="pmid">12110527</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perheentupa</surname> <given-names>J</given-names></name> <name><surname>Raivio</surname> <given-names>K</given-names></name></person-group>. <article-title>Fructose-induced hyperuricaemia</article-title>. <source>Lancet (London, England).</source> (<year>1967</year>) <volume>2</volume>:<fpage>528</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(67)90494-1</pub-id><pub-id pub-id-type="pmid">4166890</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanhope</surname> <given-names>KL</given-names></name> <name><surname>Bremer</surname> <given-names>AA</given-names></name> <name><surname>Medici</surname> <given-names>V</given-names></name> <name><surname>Nakajima</surname> <given-names>K</given-names></name> <name><surname>Ito</surname> <given-names>Y</given-names></name> <name><surname>Nakano</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women</article-title>. <source>J Clin Endocrinol Metab.</source> (<year>2011</year>) <volume>96</volume>:<fpage>E1596</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2011-1251</pub-id><pub-id pub-id-type="pmid">21849529</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hydes</surname> <given-names>T</given-names></name> <name><surname>Alam</surname> <given-names>U</given-names></name> <name><surname>Cuthbertson</surname> <given-names>DJ</given-names></name></person-group>. <article-title>The impact of macronutrient intake on non-alcoholic fatty liver disease (NAFLD): too much fat, too much carbohydrate, or just too many calories?</article-title> <source>Front Nutr.</source> (<year>2021</year>) <volume>8</volume>:<fpage>640557</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2021.640557</pub-id><pub-id pub-id-type="pmid">33665203</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>ME</given-names></name> <name><surname>Xanthakis</surname> <given-names>V</given-names></name> <name><surname>Moore</surname> <given-names>LL</given-names></name> <name><surname>Vasan</surname> <given-names>RS</given-names></name> <name><surname>Jacques</surname> <given-names>PF</given-names></name></person-group>. <article-title>Cumulative sugar-sweetened beverage consumption is associated with higher concentrations of circulating ceramides in the Framingham Offspring Cohort</article-title>. <source>Am J Clin Nutr.</source> (<year>2020</year>) <volume>111</volume>:<fpage>420</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/nqz257</pub-id><pub-id pub-id-type="pmid">31826243</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crescenzo</surname> <given-names>R</given-names></name> <name><surname>Mazzoli</surname> <given-names>A</given-names></name> <name><surname>Di Luccia</surname> <given-names>B</given-names></name> <name><surname>Bianco</surname> <given-names>F</given-names></name> <name><surname>Cancelliere</surname> <given-names>R</given-names></name> <name><surname>Cigliano</surname> <given-names>L</given-names></name></person-group>. <article-title>Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation</article-title>. <source>Food Nutr Res.</source> (<year>2017</year>) <volume>61</volume>:<fpage>1331657</fpage>. <pub-id pub-id-type="doi">10.1080/16546628.2017.1331657</pub-id><pub-id pub-id-type="pmid">28659742</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matafome</surname> <given-names>P</given-names></name> <name><surname>Sena</surname> <given-names>C</given-names></name> <name><surname>Sei&#x000E7;a</surname> <given-names>R</given-names></name></person-group>. <article-title>Methylglyoxal, obesity, and diabetes</article-title>. <source>Endocrine.</source> (<year>2013</year>) <volume>43</volume>:<fpage>472</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-012-9795-8</pub-id><pub-id pub-id-type="pmid">22983866</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gugliucci</surname> <given-names>A</given-names></name></person-group>. <article-title>Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases</article-title>. <source>Adv Nutr.</source> (<year>2017</year>) <volume>8</volume>:<fpage>54</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.3945/an.116.013912</pub-id><pub-id pub-id-type="pmid">28096127</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Moran</surname> <given-names>G</given-names></name> <name><surname>Estrada</surname> <given-names>A</given-names></name> <name><surname>Pagliassotti</surname> <given-names>MJ</given-names></name></person-group>. <article-title>Fructose-induced stress signaling in the liver involves methylglyoxal</article-title>. <source>Nutr Metab (Lond).</source> (<year>2013</year>) <volume>10</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-10-32</pub-id><pub-id pub-id-type="pmid">23566306</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>SZ</given-names></name> <name><surname>Empie</surname> <given-names>MW</given-names></name></person-group>. <article-title>Fructose metabolism in humans-what isotopic tracer studies tell us</article-title>. <source>Nutr Metab (Lond).</source> (<year>2012</year>) <volume>9</volume>:<fpage>89</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-9-89</pub-id><pub-id pub-id-type="pmid">23031075</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Stenvinkel</surname> <given-names>P</given-names></name> <name><surname>Jensen</surname> <given-names>T</given-names></name> <name><surname>Lanaspa</surname> <given-names>MA</given-names></name> <name><surname>Roncal</surname> <given-names>C</given-names></name> <name><surname>Song</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Metabolic and kidney diseases in the setting of climate change, water shortage, and survival factors</article-title>. <source>J Am Soc Nephrol.</source> (<year>2016</year>) <volume>27</volume>:<fpage>2247</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2015121314</pub-id><pub-id pub-id-type="pmid">27283495</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stenvinkel</surname> <given-names>P</given-names></name> <name><surname>Fr&#x000F6;bert</surname> <given-names>O</given-names></name> <name><surname>Anderstam</surname> <given-names>B</given-names></name> <name><surname>Palm</surname> <given-names>F</given-names></name> <name><surname>Eriksson</surname> <given-names>M</given-names></name> <name><surname>Bragfors-Helin</surname> <given-names>AC</given-names></name> <etal/></person-group>. <article-title>Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos)</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e72934</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0072934</pub-id><pub-id pub-id-type="pmid">24039826</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carrera-Bastos</surname> <given-names>P</given-names></name> <name><surname>Fontes O&#x00027;Keefe</surname> <given-names>J</given-names></name> <name><surname>Lindeberg</surname> <given-names>S</given-names></name> <name><surname>Cordain</surname> <given-names>L</given-names></name></person-group>. <article-title>The western diet and lifestyle and diseases of civilization</article-title>. <source>Res Reports Clin Cardiol</source>. (<year>2011</year>) <volume>15</volume>:<fpage>35</fpage>. <pub-id pub-id-type="doi">10.2147/RRCC.S16919</pub-id><pub-id pub-id-type="pmid">31695465</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Sautin</surname> <given-names>YY</given-names></name> <name><surname>Oliver</surname> <given-names>WJ</given-names></name> <name><surname>Roncal</surname> <given-names>C</given-names></name> <name><surname>Mu</surname> <given-names>W</given-names></name> <name><surname>Gabriela Sanchez-Lozada</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?</article-title> <source>J Comp Physiol B.</source> (<year>2009</year>) <volume>179</volume>:<fpage>67</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s00360-008-0291-7</pub-id><pub-id pub-id-type="pmid">18649082</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Andrews</surname> <given-names>P</given-names></name> <name><surname>Benner</surname> <given-names>SA</given-names></name> <name><surname>Oliver</surname> <given-names>W.</given-names></name> <name><surname>Theodore</surname> <given-names>E</given-names></name></person-group>. <article-title>Woodward award. The evolution of obesity: insights from the mid-Miocene</article-title>. <source>Trans Am Clin Climatol Assoc</source>. (<year>2010</year>) <volume>121</volume>:<fpage>295</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="pmid">20697570</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kratzer</surname> <given-names>JT</given-names></name> <name><surname>Lanaspa</surname> <given-names>MA</given-names></name> <name><surname>Murphy</surname> <given-names>MN</given-names></name> <name><surname>Cicerchi</surname> <given-names>C</given-names></name> <name><surname>Graves</surname> <given-names>CL</given-names></name> <name><surname>Tipton</surname> <given-names>PA</given-names></name> <etal/></person-group>. <article-title>Evolutionary history and metabolic insights of ancient mammalian uricases</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2014</year>) <volume>111</volume>:<fpage>3763</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1320393111</pub-id><pub-id pub-id-type="pmid">24550457</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feig</surname> <given-names>DI</given-names></name> <name><surname>Madero</surname> <given-names>M</given-names></name> <name><surname>Jalal</surname> <given-names>DI</given-names></name> <name><surname>Sanchez-Lozada</surname> <given-names>LG</given-names></name> <name><surname>Johnson</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Uric acid and the origins of hypertension</article-title>. <source>J Pediatr.</source> (<year>2013</year>) <volume>162</volume>:<fpage>896</fpage>&#x02013;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2012.12.078</pub-id><pub-id pub-id-type="pmid">23403249</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>S&#x000E1;nchez-Lozada</surname> <given-names>LG</given-names></name> <name><surname>Andrews</surname> <given-names>P</given-names></name> <name><surname>Lanaspa</surname> <given-names>MA</given-names></name></person-group>. <article-title>Perspective: a historical and scientific perspective of sugar and its relation with obesity and diabetes</article-title>. <source>Adv Nutr.</source> (<year>2017</year>) <volume>8</volume>:<fpage>412</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.3945/an.116.014654</pub-id><pub-id pub-id-type="pmid">28507007</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmberg</surname> <given-names>NG</given-names></name> <name><surname>Kaplan</surname> <given-names>B</given-names></name> <name><surname>Karvonen</surname> <given-names>MJ</given-names></name> <name><surname>Lind</surname> <given-names>J</given-names></name> <name><surname>Malm</surname> <given-names>M</given-names></name></person-group>. <article-title>Permeability of human placenta to glucose, fructose, and xylose</article-title>. <source>Acta Physiologica Scandinavica</source>. (<year>1956</year>) <volume>36</volume>:<fpage>2943</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.1956.tb01326.x</pub-id><pub-id pub-id-type="pmid">13313227</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quraishi</surname> <given-names>N</given-names></name> <name><surname>Illsley</surname> <given-names>NP</given-names></name></person-group>. <article-title>Transport of sugars across human placental membranes measured by light scattering</article-title>. <source>Placenta.</source> (<year>1999</year>) <volume>20</volume>:<fpage>167</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1053/plac.1998.0365</pub-id><pub-id pub-id-type="pmid">10195737</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname> <given-names>R</given-names></name> <name><surname>Carayannopoulos</surname> <given-names>MO</given-names></name> <name><surname>Dowd</surname> <given-names>LO</given-names></name> <name><surname>Phay</surname> <given-names>JE</given-names></name> <name><surname>Moley</surname> <given-names>JF</given-names></name> <name><surname>Moley</surname> <given-names>KH</given-names></name></person-group>. <article-title>Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking</article-title>. <source>J Biol Chem.</source> (<year>2004</year>) <volume>279</volume>:<fpage>16229</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M312226200</pub-id><pub-id pub-id-type="pmid">14739288</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname> <given-names>DD</given-names></name> <name><surname>Roux</surname> <given-names>J</given-names></name> <name><surname>Villee</surname> <given-names>CA</given-names></name></person-group>. <article-title>Studies of the mechanism of fructose production by human placenta</article-title>. <source>J Physiol.</source> (<year>1959</year>) <volume>146</volume>:<fpage>98</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1959.sp006180</pub-id><pub-id pub-id-type="pmid">13655218</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trindade</surname> <given-names>CEP</given-names></name> <name><surname>Barreiros</surname> <given-names>RC</given-names></name> <name><surname>Kurokawa</surname> <given-names>C</given-names></name> <name><surname>Bossolan</surname> <given-names>G</given-names></name></person-group>. <article-title>ructose in fetal cord blood and its relationship with maternal and 48-hour-newborn blood concentrations</article-title>. <source>Early Hum Dev.</source> (<year>2011</year>) <volume>87</volume>:<fpage>193</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2010.12.005</pub-id><pub-id pub-id-type="pmid">21276669</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>George</surname> <given-names>GC</given-names></name> <name><surname>Hanss-Nuss</surname> <given-names>H</given-names></name> <name><surname>Milani</surname> <given-names>TJ</given-names></name> <name><surname>Freeland-Graves</surname> <given-names>JH</given-names></name></person-group>. <article-title>Food choices of low-income women during pregnancy and postpartum</article-title>. <source>J Am Diet Assoc.</source> (<year>2005</year>) <volume>105</volume>:<fpage>899</fpage>&#x02013;<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.jada.2005.03.028</pub-id><pub-id pub-id-type="pmid">15942539</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brantsaeter</surname> <given-names>AL</given-names></name> <name><surname>Haugen</surname> <given-names>M</given-names></name> <name><surname>Samuelsen</surname> <given-names>SO</given-names></name></person-group>. <article-title>A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant norwegian women</article-title>. <source>J. Nutr.</source> (<year>2009</year>) <volume>139</volume>:<fpage>1162</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3945/jn.109.104968</pub-id><pub-id pub-id-type="pmid">19369368</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borgen</surname> <given-names>I</given-names></name> <name><surname>Aamodt</surname> <given-names>G</given-names></name> <name><surname>Harsem</surname> <given-names>N</given-names></name> <name><surname>Haugen</surname> <given-names>M</given-names></name> <name><surname>Meltzer</surname> <given-names>HM</given-names></name> <name><surname>Brants&#x000E6;ter</surname> <given-names>AL</given-names></name></person-group>. <article-title>Maternal sugar consumption and risk of preeclampsia in nulliparous norwegian women</article-title>. <source>Eur J Clin Nutr.</source> (<year>2012</year>) <volume>66</volume>:<fpage>920</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/ejcn.2012.61</pub-id><pub-id pub-id-type="pmid">22713766</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Englund-Ogge</surname> <given-names>L</given-names></name> <name><surname>Brantseter</surname> <given-names>AL</given-names></name> <name><surname>Haugen</surname> <given-names>M</given-names></name></person-group>. <article-title>Association between intake of artificially sweetened and sugar-sweetened beverages and preterm delivery: a large prospective cohort study</article-title>. <source>Am J Clin Nutr.</source> (<year>2012</year>) <volume>96</volume>:<fpage>552</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.111.031567</pub-id><pub-id pub-id-type="pmid">22854404</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jen</surname> <given-names>KL</given-names></name> <name><surname>Rochon</surname> <given-names>C</given-names></name> <name><surname>Zhong</surname> <given-names>SB</given-names></name> <name><surname>Whitcomb</surname> <given-names>L</given-names></name></person-group>. <article-title>Fructose and sucrose feeding during pregnancy and lactation in rats changes maternal and pup fuel metabolism</article-title>. <source>J. Nutr.</source> (<year>1991</year>) <volume>121</volume>:<fpage>1999</fpage>&#x02013;<lpage>2005</lpage>. <pub-id pub-id-type="doi">10.1093/jn/121.12.1999</pub-id><pub-id pub-id-type="pmid">1941264</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>M</given-names></name> <name><surname>Arentson</surname> <given-names>EJ</given-names></name> <name><surname>Teegarden</surname> <given-names>D</given-names></name> <name><surname>Koser</surname> <given-names>SL</given-names></name> <name><surname>Onyskow</surname> <given-names>L</given-names></name> <name><surname>Donkin</surname> <given-names>SS</given-names></name></person-group>. <article-title>Fructose consumption during pregnancy and lactation induces fatty liver and glucose intolerance in rats</article-title>. <source>Nutr Res.</source> (<year>2012</year>) <volume>32</volume>:<fpage>588</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutres.2012.06.012</pub-id><pub-id pub-id-type="pmid">22935342</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawana</surname> <given-names>S</given-names></name> <name><surname>Clark</surname> <given-names>K</given-names></name> <name><surname>Zhong</surname> <given-names>S</given-names></name> <name><surname>Buison</surname> <given-names>A</given-names></name> <name><surname>Chackunkal</surname> <given-names>S</given-names></name> <name><surname>Jen</surname> <given-names>KL</given-names></name></person-group>. <article-title>Low dose fructose ingestion during gestation and lactation affects carbohydrate metabolism in rat dams and their offspring</article-title>. <source>J Nutr.</source> (<year>1993</year>) <volume>123</volume>:<fpage>2158</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="pmid">8263611</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alzamendi</surname> <given-names>A</given-names></name> <name><surname>Del Zotto</surname> <given-names>H</given-names></name> <name><surname>Castrogiovanni</surname> <given-names>D</given-names></name> <name><surname>Romero</surname> <given-names>J</given-names></name> <name><surname>Giovambattista</surname> <given-names>A</given-names></name> <name><surname>Spinedi</surname> <given-names>E</given-names></name></person-group>. <article-title>Oral metformin treatment prevents enhanced insulin demand and placental dysfunction in the pregnant rat fed a fructose-rich diet</article-title>. <source>ISRN Endocrinol.</source> (<year>2012</year>) <volume>2012</volume>:<fpage>757913</fpage>. <pub-id pub-id-type="doi">10.5402/2012/757913</pub-id><pub-id pub-id-type="pmid">22957268</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname> <given-names>C</given-names></name> <name><surname>Long</surname> <given-names>S</given-names></name> <name><surname>Green</surname> <given-names>C</given-names></name> <name><surname>Gardiner</surname> <given-names>SM</given-names></name> <name><surname>Craigon</surname> <given-names>J</given-names></name> <name><surname>Gardner</surname> <given-names>DS</given-names></name></person-group>. <article-title>Maternal fructose and/or salt intake and reproductive outcome in the rat. Effects on growth, fertility, sex ratio, and birth order</article-title>. <source>Biol Reprod.</source> (<year>2013</year>) <volume>83</volume>:<fpage>51</fpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.113.109595</pub-id><pub-id pub-id-type="pmid">23759309</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cambri</surname> <given-names>LT</given-names></name> <name><surname>Ghezzi</surname> <given-names>AC</given-names></name> <name><surname>Ribeiro</surname> <given-names>C</given-names></name> <name><surname>Dalia</surname> <given-names>RA</given-names></name> <name><surname>de Mello</surname> <given-names>MA</given-names></name></person-group>. <article-title>Recovery of rat growth and lipid profiles in adult rats subjected to fetal protein malnutrition with a fructose-rich diet</article-title>. <source>Nutr. Res.</source> (<year>2010</year>) <volume>30</volume>:<fpage>156</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutres.2010.01.001</pub-id><pub-id pub-id-type="pmid">20227002</pub-id></citation></ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alzamendi</surname> <given-names>A</given-names></name> <name><surname>Castrogiovanni</surname> <given-names>D</given-names></name> <name><surname>Gaillard</surname> <given-names>RC</given-names></name> <name><surname>Spinedi</surname> <given-names>E</given-names></name> <name><surname>Giovambattista</surname> <given-names>A</given-names></name></person-group>. <article-title>Increased male offspring&#x00027;s risk of metabolic&#x02013; neuroendocrine dysfunction and overweight after fructose-rich diet intake by the lactating mother</article-title>. <source>Endocrinology.</source> (<year>2010</year>) <volume>151</volume>:<fpage>4214</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-1353</pub-id><pub-id pub-id-type="pmid">20660072</pub-id></citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ED;gueza</surname> <given-names>L</given-names></name> <name><surname>Panaderoa</surname> <given-names>MI</given-names></name> <name><surname>Roglansb</surname> <given-names>N</given-names></name> <name><surname>Oteroa</surname> <given-names>P</given-names></name> <name><surname>&#x000C1;lvarez-Mill&#x000E1;nc</surname> <given-names>JJ</given-names></name> <name><surname>Lagunab</surname> <given-names>JC</given-names></name> <name><surname>Bocos</surname> <given-names>C</given-names></name></person-group>. <article-title>Fructose during pregnancy affects maternal and fetal leptin signaling</article-title>. <source>J Nutr Biochem.</source> (<year>2013</year>) <volume>24</volume>:<fpage>1709</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.02.011</pub-id><pub-id pub-id-type="pmid">23643523</pub-id></citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saad</surname> <given-names>AF</given-names></name> <name><surname>Dickerson</surname> <given-names>J</given-names></name> <name><surname>Kechichian</surname> <given-names>TB</given-names></name> <name><surname>Yin</surname> <given-names>H</given-names></name> <name><surname>Gamble</surname> <given-names>P</given-names></name> <name><surname>Salazar</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring</article-title>. <source>Am J Obstet Gynecol.</source> (<year>2016</year>) <volume>215</volume>:<fpage>378. e1</fpage>&#x02013;<lpage>378.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2016.03.038</pub-id><pub-id pub-id-type="pmid">27060421</pub-id></citation></ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>J</given-names></name> <name><surname>Feng</surname> <given-names>Q</given-names></name> <name><surname>Zhang</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>T</given-names></name> <name><surname>Xiao</surname> <given-names>X</given-names></name></person-group>. <article-title>Early life fructose exposure and its implications for long-term cardiometabolic health in offspring</article-title>. <source>Nutrients.</source> (<year>2016</year>) <volume>8</volume>:<fpage>E685</fpage>. <pub-id pub-id-type="doi">10.3390/nu8110685</pub-id><pub-id pub-id-type="pmid">27809266</pub-id></citation></ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>CN</given-names></name> <name><surname>Lin</surname> <given-names>YJ</given-names></name> <name><surname>Hou</surname> <given-names>CY</given-names></name> <name><surname>Tain</surname> <given-names>YL</given-names></name></person-group>. <article-title>Maternal administration of probiotic or prebiotic prevents male adult rat offspring against developmental programming of hypertension induced by high fructose consumption in pregnancy and lactation</article-title>. <source>Nutrients.</source> (<year>2018</year>) <volume>10</volume>:<fpage>E1229</fpage>. <pub-id pub-id-type="doi">10.3390/nu10091229</pub-id><pub-id pub-id-type="pmid">30181501</pub-id></citation></ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seong</surname> <given-names>HY</given-names></name> <name><surname>Cho</surname> <given-names>HM</given-names></name> <name><surname>Kim</surname> <given-names>M</given-names></name> <name><surname>Kim</surname> <given-names>I</given-names></name></person-group>. <article-title>Maternal high-fructose intake induces multigenerational activation of the renin-angiotensin-aldosterone system</article-title>. <source>Hypertension.</source> (<year>2019</year>) <volume>74</volume>:<fpage>518</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.12941</pub-id><pub-id pub-id-type="pmid">31327271</pub-id></citation></ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname> <given-names>M</given-names></name> <name><surname>Luiken</surname> <given-names>JJP</given-names></name> <name><surname>Coumans</surname> <given-names>W</given-names></name> <name><surname>Bell</surname> <given-names>RC</given-names></name></person-group>. <article-title>Dietary fructose during the suckling period increases body weight and fatty acid uptake into skeletal muscle in adult rats</article-title>. <source>Obesity (Silver Spring).</source> (<year>2008</year>) <volume>16</volume>:<fpage>1755</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2008.268</pub-id><pub-id pub-id-type="pmid">18483476</pub-id></citation></ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goran</surname> <given-names>MI</given-names></name> <name><surname>Martin</surname> <given-names>AA</given-names></name> <name><surname>Alderete</surname> <given-names>TL</given-names></name> <name><surname>Fujiwara</surname> <given-names>HA</given-names></name></person-group>. <article-title>Field DAs fructose in breast milk is positively associated with infant body composition at 6 months of age</article-title>. <source>Nutrients.</source> (<year>2017</year>) <volume>9</volume>:<fpage>146</fpage>. <pub-id pub-id-type="doi">10.3390/nu9020146</pub-id><pub-id pub-id-type="pmid">28212335</pub-id></citation></ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocarsly</surname> <given-names>ME</given-names></name> <name><surname>Powell</surname> <given-names>ES</given-names></name> <name><surname>Avena</surname> <given-names>NM</given-names></name> <name><surname>Hoebel</surname> <given-names>BG</given-names></name></person-group>. <article-title>High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels</article-title>. <source>Pharmacol Biochem Behav.</source> (<year>2010</year>) <volume>97</volume>:<fpage>101</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2010.02.012</pub-id><pub-id pub-id-type="pmid">20219526</pub-id></citation></ref>
<ref id="B68">
<label>68.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>F</given-names></name> <name><surname>Gilani</surname> <given-names>AH</given-names></name></person-group>. <article-title>Fiber-free white flour with fructose offers a better model of metabolic syndrome</article-title>. <source>Lipids Health Dis.</source> (<year>2013</year>) <volume>28</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1186/1476-511X-12-44</pub-id><pub-id pub-id-type="pmid">23537367</pub-id></citation></ref>
<ref id="B69">
<label>69.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname> <given-names>A</given-names></name> <name><surname>Mu</surname> <given-names>W</given-names></name> <name><surname>Roncal</surname> <given-names>C</given-names></name> <name><surname>Cheng</surname> <given-names>KY</given-names></name> <name><surname>Johnson</surname> <given-names>RJ</given-names></name> <name><surname>Scarpace</surname> <given-names>PJ</given-names></name></person-group>. <article-title>Fructose induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source> (<year>2008</year>) <volume>295</volume>:<fpage>R1370</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00195.2008</pub-id><pub-id pub-id-type="pmid">18784330</pub-id></citation></ref>
<ref id="B70">
<label>70.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Haschimi</surname> <given-names>K</given-names></name> <name><surname>Pierroz</surname> <given-names>DD</given-names></name> <name><surname>Hileman</surname> <given-names>SM</given-names></name> <name><surname>Bj&#x000F8;rb&#x000E6;k</surname> <given-names>C</given-names></name> <name><surname>Flier</surname> <given-names>JS</given-names></name></person-group>. <article-title>Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity</article-title>. <source>J Clin Invest.</source> (<year>2000</year>) <volume>105</volume>:<fpage>1827</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1172/JCI9842</pub-id><pub-id pub-id-type="pmid">10862798</pub-id></citation></ref>
<ref id="B71">
<label>71.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scarpace</surname> <given-names>PJ</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name></person-group>. <article-title>Elevated leptin: consequence or cause of obesity?</article-title> <source>Front Biosci.</source> (<year>2007</year>) <volume>12</volume>:<fpage>3531</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.2741/2332</pub-id><pub-id pub-id-type="pmid">17485319</pub-id></citation></ref>
<ref id="B72">
<label>72.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindqvist</surname> <given-names>A</given-names></name> <name><surname>Baelemans</surname> <given-names>A</given-names></name> <name><surname>Erlanson-Albertsson</surname> <given-names>C</given-names></name></person-group>. <article-title>Effects of sucrose, glucose and fructose on peripheral and central appetite signals</article-title>. <source>Regul Pept.</source> (<year>2008</year>) <volume>150</volume>:<fpage>26</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2008.06.008</pub-id><pub-id pub-id-type="pmid">18627777</pub-id></citation></ref>
<ref id="B73">
<label>73.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000E1;ndez-D&#x000ED;azcouder</surname> <given-names>A</given-names></name> <name><surname>Romero-Nava</surname> <given-names>R</given-names></name> <name><surname>Carb&#x000F3;</surname> <given-names>R</given-names></name> <name><surname>S&#x000E1;nchez-Lozada</surname> <given-names>LG</given-names></name> <name><surname>S&#x000E1;nchez-Mu&#x000F1;oz</surname> <given-names>F</given-names></name></person-group>. <article-title>High fructose intake and adipogenesis</article-title>. <source>Int J Mol Sci</source>. (<year>2019</year>) <volume>20</volume>:<fpage>2787</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20112787</pub-id><pub-id pub-id-type="pmid">31181590</pub-id></citation></ref>
<ref id="B74">
<label>74.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Te Morenga</surname> <given-names>L</given-names></name> <name><surname>Mallard</surname> <given-names>S</given-names></name> <name><surname>Mann</surname> <given-names>J</given-names></name></person-group>. <article-title>Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies</article-title>. <source>BMJ.</source> (<year>2012</year>) <volume>346</volume>:<fpage>e7492</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.e7492</pub-id><pub-id pub-id-type="pmid">23321486</pub-id></citation></ref>
<ref id="B75">
<label>75.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname> <given-names>L</given-names></name> <name><surname>Farmer</surname> <given-names>A</given-names></name> <name><surname>Girard</surname> <given-names>M</given-names></name> <name><surname>Peterson</surname> <given-names>K</given-names></name></person-group>. <article-title>Regular sugar-sweetened beverage consumption between meals increases risk of overweight among preschool-aged children</article-title>. <source>J Am Diet Assoc.</source> (<year>2007</year>) <volume>107</volume>:<fpage>924</fpage>&#x02013;<lpage>34</lpage>; discussion 934&#x02013;5. <pub-id pub-id-type="doi">10.1016/j.jada.2007.03.004</pub-id><pub-id pub-id-type="pmid">17524711</pub-id></citation></ref>
<ref id="B76">
<label>76.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kral</surname> <given-names>TVE</given-names></name> <name><surname>Stunkard</surname> <given-names>AJ</given-names></name> <name><surname>Berkowitz</surname> <given-names>RI</given-names></name> <name><surname>Stallings</surname> <given-names>VA</given-names></name> <name><surname>Moore</surname> <given-names>RH</given-names></name> <name><surname>Faith</surname> <given-names>MS</given-names></name></person-group>. <article-title>Beverage consumption patterns of children born at different risk of obesity</article-title>. <source>Obesity.</source> (<year>2008</year>) <volume>16</volume>:<fpage>1802</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2008.287</pub-id><pub-id pub-id-type="pmid">18535546</pub-id></citation></ref>
<ref id="B77">
<label>77.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>S</given-names></name> <name><surname>Zoellner</surname> <given-names>JM</given-names></name> <name><surname>Lee</surname> <given-names>JM</given-names></name> <name><surname>Burt</surname> <given-names>BA</given-names></name> <name><surname>Sandretto</surname> <given-names>AM</given-names></name> <name><surname>Sohn</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Obesity and sugar-sweetened beverages in african-american preschool children: a longitudinal study</article-title>. <source>Obesity.</source> (<year>2009</year>) <volume>17</volume>:<fpage>1262</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2008.656</pub-id><pub-id pub-id-type="pmid">19197261</pub-id></citation></ref>
<ref id="B78">
<label>78.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quah</surname> <given-names>PL</given-names></name> <name><surname>Kleijweg</surname> <given-names>J</given-names></name> <name><surname>Chang</surname> <given-names>YY</given-names></name> <name><surname>Toh</surname> <given-names>JY</given-names></name> <name><surname>Lim</surname> <given-names>HX</given-names></name> <name><surname>Sugianto</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Association of sugar-sweetened beverage intake at 18 months and 5 years of age with adiposity outcomes at 6 years of age: the Singapore GUSTO mother-offspring cohort</article-title>. <source>Br J Nutr.</source> (<year>2019</year>) <volume>122</volume>:<fpage>1303</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114519002253</pub-id><pub-id pub-id-type="pmid">31477198</pub-id></citation></ref>
<ref id="B79">
<label>79.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herbst</surname> <given-names>A</given-names></name> <name><surname>Diethelm</surname> <given-names>K</given-names></name> <name><surname>Cheng</surname> <given-names>G</given-names></name> <name><surname>Alexy</surname> <given-names>U</given-names></name> <name><surname>Icks</surname> <given-names>A</given-names></name> <name><surname>Buyken</surname> <given-names>AE</given-names></name></person-group>. <article-title>Direction of associations between added sugar intake in early childhood and body mass index at age 7 years may depend on intake levels</article-title>. <source>J Nutr.</source> (<year>2011</year>) <volume>141</volume>:<fpage>1348</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.3945/jn.110.137000</pub-id><pub-id pub-id-type="pmid">21562234</pub-id></citation></ref>
<ref id="B80">
<label>80.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berkey</surname> <given-names>CS</given-names></name> <name><surname>Rockett</surname> <given-names>HRH</given-names></name> <name><surname>Field</surname> <given-names>AE</given-names></name> <name><surname>Gillman</surname> <given-names>MW</given-names></name> <name><surname>Colditz</surname> <given-names>GA</given-names></name></person-group>. <article-title>Sugar-added beverages and adolescent weight change</article-title>. <source>Obes Res.</source> (<year>2004</year>) <volume>12</volume>:<fpage>778</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2004.94</pub-id><pub-id pub-id-type="pmid">15166298</pub-id></citation></ref>
<ref id="B81">
<label>81.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T</given-names></name> <name><surname>Yeung</surname> <given-names>SLA</given-names></name> <name><surname>Kwok</surname> <given-names>MK</given-names></name> <name><surname>Hui</surname> <given-names>LL</given-names></name> <name><surname>Leung</surname> <given-names>GM</given-names></name> <name><surname>Schooling</surname> <given-names>CM</given-names></name></person-group>. <article-title>Association of sugar-sweetened beverage frequency with adiposity: evidence from the &#x0201C;children of 1997&#x0201D; birth cohort</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>1015</fpage>. <pub-id pub-id-type="doi">10.3390/nu12041015</pub-id><pub-id pub-id-type="pmid">32272690</pub-id></citation></ref>
<ref id="B82">
<label>82.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname> <given-names>RP</given-names></name></person-group>. <article-title>Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes</article-title>. <source>J Biol Chem.</source> (<year>2004</year>) <volume>279</volume>:<fpage>42351</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R400019200</pub-id><pub-id pub-id-type="pmid">15258147</pub-id></citation></ref>
<ref id="B83">
<label>83.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname> <given-names>M</given-names></name> <name><surname>Bezerra</surname> <given-names>RMN</given-names></name> <name><surname>Silva</surname> <given-names>MS</given-names></name> <name><surname>Tavares</surname> <given-names>DQ</given-names></name> <name><surname>Carvalho</surname> <given-names>CR</given-names></name> <name><surname>Saad</surname> <given-names>MJA</given-names></name></person-group>. <article-title>A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats</article-title>. <source>Braz J Med Biol Res.</source> (<year>2000</year>) <volume>33</volume>:<fpage>1421</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1590/S0100-879X2000001200004</pub-id><pub-id pub-id-type="pmid">11105093</pub-id></citation></ref>
<ref id="B84">
<label>84.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Despr&#x000E9;s</surname> <given-names>JP</given-names></name> <name><surname>Lemieux</surname> <given-names>I</given-names></name> <name><surname>Bergeron</surname> <given-names>J</given-names></name> <name><surname>Pibarot</surname> <given-names>P</given-names></name> <name><surname>Mathieu</surname> <given-names>P</given-names></name> <name><surname>Larose</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk, Arterioscler</article-title>. <source>Thromb Vasc Biol.</source> (<year>2008</year>) <volume>28</volume>:<fpage>1039</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.107.159228</pub-id><pub-id pub-id-type="pmid">18356555</pub-id></citation></ref>
<ref id="B85">
<label>85.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aeberli</surname> <given-names>I</given-names></name> <name><surname>Hochuli</surname> <given-names>M</given-names></name> <name><surname>Gerber</surname> <given-names>PA</given-names></name> <name><surname>Sze</surname> <given-names>L</given-names></name> <name><surname>Murer</surname> <given-names>SB</given-names></name> <name><surname>Tappy</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial</article-title>. <source>Diabetes Care.</source> (<year>2013</year>) <volume>36</volume>:<fpage>150</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2337/dc12-0540</pub-id><pub-id pub-id-type="pmid">23801807</pub-id></citation></ref>
<ref id="B86">
<label>86.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lytrivi</surname> <given-names>M</given-names></name> <name><surname>Ghaddar</surname> <given-names>K</given-names></name> <name><surname>Lopes</surname> <given-names>M</given-names></name> <name><surname>Rosengren</surname> <given-names>V</given-names></name> <name><surname>Piron</surname> <given-names>A</given-names></name> <name><surname>Yi</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Combined transcriptome and proteome profiling of the pancreatic &#x003B2;-cell response to palmitate unveils key pathways of &#x003B2;-cell lipotoxicity</article-title>. <source>BMC Genomics.</source> (<year>2020</year>) <volume>21</volume>:<fpage>590</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-020-07003-0</pub-id><pub-id pub-id-type="pmid">32847508</pub-id></citation></ref>
<ref id="B87">
<label>87.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>CR</given-names></name> <name><surname>Bueno</surname> <given-names>AA</given-names></name> <name><surname>Mattos</surname> <given-names>AM</given-names></name> <name><surname>Biz</surname> <given-names>C</given-names></name> <name><surname>De Oliveira</surname> <given-names>C</given-names></name> <name><surname>Pisani</surname> <given-names>LP</given-names></name> <etal/></person-group>. <article-title>Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes</article-title>. <source>Nutr Res.</source> (<year>2010</year>) <volume>30</volume>:<fpage>644</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutres.2010.06.012</pub-id><pub-id pub-id-type="pmid">20934606</pub-id></citation></ref>
<ref id="B88">
<label>88.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>R</given-names></name> <name><surname>Barden</surname> <given-names>A</given-names></name> <name><surname>Mori</surname> <given-names>T</given-names></name> <name><surname>Beilin</surname> <given-names>L</given-names></name></person-group>. <article-title>Advanced glycation end-products: a review</article-title>. <source>Diabetologia</source>. (<year>2001</year>) <volume>44</volume>:<fpage>129</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s001250051591</pub-id><pub-id pub-id-type="pmid">11270668</pub-id></citation></ref>
<ref id="B89">
<label>89.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanaspa</surname> <given-names>MA</given-names></name> <name><surname>Ishimoto</surname> <given-names>T</given-names></name> <name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Cicerchi</surname> <given-names>C</given-names></name> <name><surname>Orlicky</surname> <given-names>DJ</given-names></name> <name><surname>Ruzicky</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome</article-title>. <source>Nat Commun.</source> (<year>2013</year>) <volume>4</volume>:<fpage>2434</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms3434</pub-id><pub-id pub-id-type="pmid">24022321</pub-id></citation></ref>
<ref id="B90">
<label>90.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenzi</surname> <given-names>M</given-names></name></person-group>. <article-title>The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient</article-title>. <source>Exp Diabetes Res.</source> (<year>2007</year>) <volume>2007</volume>:<fpage>61038</fpage>. <pub-id pub-id-type="doi">10.1155/2007/61038</pub-id><pub-id pub-id-type="pmid">18224243</pub-id></citation></ref>
<ref id="B91">
<label>91.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>JM</given-names></name> <name><surname>Divers</surname> <given-names>J</given-names></name> <name><surname>Isom</surname> <given-names>S</given-names></name> <name><surname>Saydah</surname> <given-names>S</given-names></name> <name><surname>Imperatore</surname> <given-names>G</given-names></name> <name><surname>Pihoker</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017</article-title>. <source>JAMA.</source> (<year>2021</year>) <volume>326</volume>:<fpage>717</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2021.11165</pub-id><pub-id pub-id-type="pmid">34427600</pub-id></citation></ref>
<ref id="B92">
<label>92.</label>
<citation citation-type="book"><person-group person-group-type="author"><collab>SACN, Scientific Scientific Advisory Committee on Nutrition</collab></person-group>. <source>Carbohydrates and Health</source>. <publisher-loc>London</publisher-loc>: <publisher-name>TSO</publisher-name> (<year>2015</year>).</citation>
</ref>
<ref id="B93">
<label>93.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>FB</given-names></name> <name><surname>Malik</surname> <given-names>VS</given-names></name></person-group>. <article-title>Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence</article-title>. <source>Physiol Behav.</source> (<year>2010</year>) <volume>100</volume>:<fpage>47</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2010.01.036</pub-id><pub-id pub-id-type="pmid">20138901</pub-id></citation></ref>
<ref id="B94">
<label>94.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname> <given-names>DC</given-names></name> <name><surname>Threapleton</surname> <given-names>DE</given-names></name> <name><surname>Evans</surname> <given-names>CEL</given-names></name> <name><surname>Cleghorn</surname> <given-names>CL</given-names></name> <name><surname>Nykjaer</surname> <given-names>C</given-names></name> <name><surname>Woodhead</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies</article-title>. <source>Br J Nutr.</source> (<year>2014</year>) <volume>112</volume>:<fpage>725</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114514001329</pub-id><pub-id pub-id-type="pmid">24932880</pub-id></citation></ref>
<ref id="B95">
<label>95.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname> <given-names>F</given-names></name> <name><surname>O&#x00027;Connor</surname> <given-names>L</given-names></name> <name><surname>Ye</surname> <given-names>Z</given-names></name> <name><surname>Mursu</surname> <given-names>J</given-names></name> <name><surname>Hayashino</surname> <given-names>Y</given-names></name> <name><surname>Bhupathiraju</surname> <given-names>SN</given-names></name> <etal/></person-group>. <article-title>Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction</article-title>. <source>BMJ.</source> (<year>2015</year>) <volume>351</volume>:<fpage>h3576</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.h3576</pub-id><pub-id pub-id-type="pmid">27044603</pub-id></citation></ref>
<ref id="B96">
<label>96.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname> <given-names>K</given-names></name> <name><surname>Kastorini</surname> <given-names>CM</given-names></name> <name><surname>Panagiotakos</surname> <given-names>DB</given-names></name> <name><surname>Giugliano</surname> <given-names>D</given-names></name></person-group>. <article-title>Prevention of type 2 diabetes by dietary patterns: a systematic review of prospective studies and meta-analysis</article-title>. <source>Metab Syndr Relat Disord.</source> (<year>2010</year>) <volume>8</volume>:<fpage>471</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/met.2010.0009</pub-id><pub-id pub-id-type="pmid">20958207</pub-id></citation></ref>
<ref id="B97">
<label>97.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname> <given-names>MB</given-names></name> <name><surname>Liu</surname> <given-names>S</given-names></name> <name><surname>Rimm</surname> <given-names>EB</given-names></name> <name><surname>Manson</surname> <given-names>JAE</given-names></name> <name><surname>Willett</surname> <given-names>WC</given-names></name> <name><surname>Hu</surname> <given-names>FB</given-names></name></person-group>. <article-title>Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women</article-title>. <source>Am J Clin Nutr.</source> (<year>2004</year>) <volume>80</volume>:<fpage>348</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/80.2.348</pub-id><pub-id pub-id-type="pmid">15277155</pub-id></citation></ref>
<ref id="B98">
<label>98.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haidari</surname> <given-names>M</given-names></name> <name><surname>Leung</surname> <given-names>N</given-names></name> <name><surname>Mahbub</surname> <given-names>F</given-names></name> <name><surname>Uffelman</surname> <given-names>KD</given-names></name> <name><surname>Kohen-Avramoglu</surname> <given-names>R</given-names></name> <name><surname>Lewis GF et</surname> <given-names>al</given-names></name></person-group>. <article-title>Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal <italic>de novo</italic> lipogenesis and ApoB48-containing lipoprotein overproduction</article-title>. <source>J Biol Chem.</source> (<year>2002</year>) <volume>277</volume>:<fpage>31646</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M200544200</pub-id><pub-id pub-id-type="pmid">12070142</pub-id></citation></ref>
<ref id="B99">
<label>99.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname> <given-names>M</given-names></name> <name><surname>Dobrzyn</surname> <given-names>A</given-names></name> <name><surname>Man</surname> <given-names>WC</given-names></name> <name><surname>Chu</surname> <given-names>K</given-names></name> <name><surname>Sampath</surname> <given-names>H</given-names></name> <name><surname>Kim</surname> <given-names>HJ</given-names></name> <etal/></person-group>. <article-title>Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms</article-title>. <source>J Biol Chem.</source> (<year>2004</year>) <volume>279</volume>:<fpage>25164</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M402781200</pub-id><pub-id pub-id-type="pmid">15066988</pub-id></citation></ref>
<ref id="B100">
<label>100.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uyeda</surname> <given-names>K</given-names></name> <name><surname>Repa</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis</article-title>. <source>Cell Metabolism.</source> (<year>2006</year>) <volume>4</volume>:<fpage>107</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2006.06.008</pub-id><pub-id pub-id-type="pmid">16890538</pub-id></citation></ref>
<ref id="B101">
<label>101.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Wahed</surname> <given-names>A</given-names></name> <name><surname>Guilmeau</surname> <given-names>S</given-names></name> <name><surname>Postic</surname> <given-names>C</given-names></name></person-group>. <article-title>Sweet sixteenth for ChREBP: established roles and future goals</article-title>. <source>Cell Metab.</source> (<year>2017</year>) <volume>26</volume>:<fpage>324</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.07.004</pub-id><pub-id pub-id-type="pmid">28768172</pub-id></citation></ref>
<ref id="B102">
<label>102.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>MS</given-names></name> <name><surname>Krawczyk</surname> <given-names>SA</given-names></name> <name><surname>Doridot</surname> <given-names>L</given-names></name> <name><surname>Fowler</surname> <given-names>AJ</given-names></name> <name><surname>Wang</surname> <given-names>JX</given-names></name> <name><surname>Trauger</surname> <given-names>SA</given-names></name> <etal/></person-group>. <article-title>ChREBP regulates fructose-induced glucose production independently of insulin signaling</article-title>. <source>J Clin Investig.</source> (<year>2016</year>) <volume>126</volume>:<fpage>4372</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1172/JCI81993</pub-id><pub-id pub-id-type="pmid">27669460</pub-id></citation></ref>
<ref id="B103">
<label>103.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannou</surname> <given-names>SA</given-names></name> <name><surname>Haslam</surname> <given-names>DE</given-names></name> <name><surname>McKeown</surname> <given-names>NM</given-names></name> <name><surname>Herman</surname> <given-names>MA</given-names></name></person-group>. <article-title>Fructose metabolism and metabolic disease</article-title>. <source>J Clin Investig.</source> (<year>2018</year>) <volume>128</volume>:<fpage>545</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1172/JCI96702</pub-id><pub-id pub-id-type="pmid">29388924</pub-id></citation></ref>
<ref id="B104">
<label>104.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname> <given-names>MA</given-names></name> <name><surname>Samuel</surname> <given-names>VT</given-names></name></person-group>. <article-title>The sweet path to metabolic demise: fructose and lipid synthesis</article-title>. <source>Trends Endocrinol Metab.</source> (<year>2016</year>) <volume>27</volume>:<fpage>719</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2016.06.005</pub-id><pub-id pub-id-type="pmid">27387598</pub-id></citation></ref>
<ref id="B105">
<label>105.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taskinen</surname> <given-names>MR</given-names></name> <name><surname>Packard</surname> <given-names>CJ</given-names></name> <name><surname>Boren</surname> <given-names>J</given-names></name></person-group>. <article-title>Emerging evidence that ApoC-III inhibitors provide novel optionsto reduce the residual CVD</article-title>. <source>Curr Atheroscler Rep.</source> (<year>2019</year>) <volume>21</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1007/s11883-019-0791-9</pub-id><pub-id pub-id-type="pmid">31111320</pub-id></citation></ref>
<ref id="B106">
<label>106.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>D</given-names></name> <name><surname>Kit</surname> <given-names>B</given-names></name> <name><surname>Carroll</surname> <given-names>M</given-names></name></person-group>. <article-title>Abnormal Cholesterol Among Children and Adolescents in the United States, 2011&#x02013;2014NCHS Data Brief No</article-title>. <volume>228</volume> (<year>2015</year>). <pub-id pub-id-type="pmid">26727279</pub-id></citation></ref>
<ref id="B107">
<label>107.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YH</given-names></name> <name><surname>An</surname> <given-names>T</given-names></name> <name><surname>Zhang</surname> <given-names>RC</given-names></name> <name><surname>Zhou</surname> <given-names>Q</given-names></name> <name><surname>Huang</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name></person-group>. <article-title>Very high fructose intake increases serum LDL-cholesterol and total cholesterol: a meta-analysis of controlled feeding trials</article-title>. <source>J Nutr.</source> (<year>2013</year>) <volume>143</volume>:<fpage>1391</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3945/jn.113.175323</pub-id><pub-id pub-id-type="pmid">23825185</pub-id></citation></ref>
<ref id="B108">
<label>108.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hieronimus</surname> <given-names>B</given-names></name> <name><surname>Medici</surname> <given-names>V</given-names></name> <name><surname>Bremer</surname> <given-names>AA</given-names></name> <name><surname>Lee</surname> <given-names>V</given-names></name> <name><surname>Nunez</surname> <given-names>MV</given-names></name> <name><surname>Sigala</surname> <given-names>DM</given-names></name> <etal/></person-group>. <article-title>Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults</article-title>. <source>Metabolism.</source> (<year>2020</year>) <volume>9</volume>:<fpage>154356</fpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2020.154356</pub-id><pub-id pub-id-type="pmid">33866221</pub-id></citation></ref>
<ref id="B109">
<label>109.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiavaroli</surname> <given-names>L</given-names></name> <name><surname>de Souza</surname> <given-names>RJ</given-names></name> <name><surname>Ha</surname> <given-names>V</given-names></name> <name><surname>Cozma</surname> <given-names>AI</given-names></name> <name><surname>Mirrahimi</surname> <given-names>A</given-names></name> <name><surname>Wang</surname> <given-names>DD</given-names></name></person-group>. <article-title>Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials</article-title>. <source>Am Heart Assoc.</source> (<year>2015</year>) <volume>4</volume>:<fpage>e001700</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.114.001700</pub-id><pub-id pub-id-type="pmid">26358358</pub-id></citation></ref>
<ref id="B110">
<label>110.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aeberli</surname> <given-names>I</given-names></name> <name><surname>Zimmermann</surname> <given-names>MB</given-names></name> <name><surname>Molinari</surname> <given-names>L</given-names></name> <name><surname>Lehmann</surname> <given-names>R</given-names></name> <name><surname>Dagmar l&#x00027;Allemand</surname> <given-names>D</given-names></name> <name><surname>Spinas</surname> <given-names>GA</given-names></name></person-group>. <article-title>Fructose intake is a predictor of LDL particle size in overweight school children</article-title>. <source>Am J Clin Nutr.</source> (<year>2007</year>) <volume>86</volume>:<fpage>1174</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/86.4.1174</pub-id><pub-id pub-id-type="pmid">17921399</pub-id></citation></ref>
<ref id="B111">
<label>111.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lustig</surname> <given-names>RH</given-names></name> <name><surname>Mulligan</surname> <given-names>K</given-names></name> <name><surname>Noworolski</surname> <given-names>SM</given-names></name> <name><surname>Tai</surname> <given-names>VW</given-names></name> <name><surname>Wen</surname> <given-names>MJ</given-names></name> <name><surname>Erkin-Cakmak</surname> <given-names>A</given-names></name></person-group>. <article-title>Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome</article-title>. <source>Obesity.</source> (<year>2016</year>) <volume>24</volume>:<fpage>453</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/oby.21371</pub-id><pub-id pub-id-type="pmid">26499447</pub-id></citation></ref>
<ref id="B112">
<label>112.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Czerwonogrodzka-Senczyna</surname> <given-names>A</given-names></name> <name><surname>Rumi&#x00144;ska</surname> <given-names>M</given-names></name> <name><surname>Majcher</surname> <given-names>A</given-names></name> <name><surname>Credo</surname> <given-names>D</given-names></name> <name><surname>Jeznach-Steinhagen</surname> <given-names>A</given-names></name> <name><surname>Beata Pyrzak</surname> <given-names>B</given-names></name></person-group>. <article-title>Fructose consumption and lipid metabolism in obese children and adolescents</article-title>. <source>Adv Exp Med Biol.</source> (<year>2019</year>) <volume>1153</volume>:<fpage>91</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1007/5584_2018_330</pub-id><pub-id pub-id-type="pmid">30701440</pub-id></citation></ref>
<ref id="B113">
<label>113.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ambrosini</surname> <given-names>GL</given-names></name> <name><surname>Oddy</surname> <given-names>WH</given-names></name> <name><surname>Huang</surname> <given-names>RC</given-names></name> <name><surname>Mori</surname> <given-names>TA</given-names></name> <name><surname>Beilin</surname> <given-names>LJ</given-names></name> <name><surname>Jebb</surname> <given-names>SA</given-names></name></person-group>. <article-title>Prospective associations between sugar-sweetened beverage intakes and cardiometabolic risk factors in adolescents</article-title>. <source>Am J Clin Nutr.</source> (<year>2013</year>) <volume>98</volume>:<fpage>327</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.112.051383</pub-id><pub-id pub-id-type="pmid">23719557</pub-id></citation></ref>
<ref id="B114">
<label>114.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname> <given-names>AA</given-names></name> <name><surname>Auinger</surname> <given-names>P</given-names></name> <name><surname>Byrd</surname> <given-names>RS</given-names></name></person-group>. <article-title>Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999-2004 National Health and Nutrition Examination Survey</article-title>. <source>Arch Pediatr Adolesc Med.</source> (<year>2009</year>) <volume>163</volume>:<fpage>328</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1001/archpediatrics.2009.21</pub-id><pub-id pub-id-type="pmid">19349561</pub-id></citation></ref>
<ref id="B115">
<label>115.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>B</given-names></name> <name><surname>Long</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>W</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Zhu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Sugar-Sweetened beverages consumption positively associated with the risks of obesity and hypertriglyceridemia among children aged 7&#x02013;18 years in South China</article-title>. <source>J Atheroscler Thromb.</source> (<year>2018</year>) <volume>25</volume>:<fpage>81</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.5551/jat.38570</pub-id><pub-id pub-id-type="pmid">28652525</pub-id></citation></ref>
<ref id="B116">
<label>116.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taskinen</surname> <given-names>MR</given-names></name> <name><surname>Soderlund</surname> <given-names>S</given-names></name> <name><surname>Bogl</surname> <given-names>LH</given-names></name> <name><surname>Hakkarainen</surname> <given-names>A</given-names></name> <name><surname>Matikainen</surname> <given-names>N</given-names></name> <name><surname>Pietilainen KH et</surname> <given-names>al</given-names></name></person-group>. <article-title>Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity</article-title>. <source>J Intern Med.</source> (<year>2017</year>) <volume>282</volume>:<fpage>187</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12632</pub-id><pub-id pub-id-type="pmid">28548281</pub-id></citation></ref>
<ref id="B117">
<label>117.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000EA;</surname> <given-names>KA</given-names></name> <name><surname>Ith</surname> <given-names>M</given-names></name> <name><surname>Kreis</surname> <given-names>R</given-names></name> <name><surname>Faeh</surname> <given-names>D</given-names></name> <name><surname>Bortolotti</surname> <given-names>M</given-names></name> <name><surname>Tran</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes</article-title>. <source>Am J Clin Nutr.</source> (<year>2009</year>) <volume>89</volume>:<fpage>1760</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2008.27336</pub-id><pub-id pub-id-type="pmid">19403641</pub-id></citation></ref>
<ref id="B118">
<label>118.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanhope</surname> <given-names>KL</given-names></name> <name><surname>Medici</surname> <given-names>V</given-names></name> <name><surname>Bremer</surname> <given-names>AA</given-names></name> <name><surname>Lee</surname> <given-names>V</given-names></name> <name><surname>Lam</surname> <given-names>HD</given-names></name> <name><surname>Nunez MV et</surname> <given-names>al</given-names></name></person-group>. <article-title>A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults</article-title>. <source>Am J Clin Nutr.</source> (<year>2015</year>) <volume>101</volume>:<fpage>1144</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.114.100461</pub-id><pub-id pub-id-type="pmid">25904601</pub-id></citation></ref>
<ref id="B119">
<label>119.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirmiran</surname> <given-names>P</given-names></name> <name><surname>Yuzbashian</surname> <given-names>E</given-names></name> <name><surname>Asghari</surname> <given-names>G</given-names></name> <name><surname>Hosseinpour-Niazi</surname> <given-names>S</given-names></name> <name><surname>Azizi</surname> <given-names>F</given-names></name></person-group>. <article-title>Consumption of sugar sweetened beverage is associated with incidence of metabolic syndromein Tehranian children and adolescents</article-title>. <source>Nutrition &#x00026; Metabolism.</source> (<year>2015</year>) <volume>12</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s12986-015-0021-6</pub-id><pub-id pub-id-type="pmid">26225136</pub-id></citation></ref>
<ref id="B120">
<label>120.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname> <given-names>S</given-names></name> <name><surname>Siri-Tarino</surname> <given-names>P</given-names></name> <name><surname>Bergeron</surname> <given-names>N</given-names></name> <name><surname>Suh</surname> <given-names>JH</given-names></name> <name><surname>Krauss</surname> <given-names>RM</given-names></name></person-group>. <article-title>A randomized study of the effect of replacing sugar-sweetened soda by reduced fat milk on cardiometabolic health in male adolescent soda drinkers</article-title>. <source>Nutrients.</source> (<year>2020</year>) <volume>12</volume>:<fpage>405</fpage>. <pub-id pub-id-type="doi">10.3390/nu12020405</pub-id><pub-id pub-id-type="pmid">32033078</pub-id></citation></ref>
<ref id="B121">
<label>121.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stefan</surname> <given-names>N</given-names></name> <name><surname>Kantartzis</surname> <given-names>K</given-names></name> <name><surname>Haring</surname> <given-names>HU</given-names></name></person-group>. <article-title>Causes and metabolic consequences of fatty liver</article-title>. <source>Endocr Rev.</source> (<year>2008</year>) <volume>29</volume>:<fpage>939</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1210/er.2008-0009</pub-id><pub-id pub-id-type="pmid">34870138</pub-id></citation></ref>
<ref id="B122">
<label>122.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cydylo</surname> <given-names>MA</given-names></name> <name><surname>Davis</surname> <given-names>AT</given-names></name> <name><surname>Kavanagh</surname> <given-names>K</given-names></name></person-group>. <article-title>Fatty liver promotes fibrosis in monkeys consuming high fructose</article-title>. <source>Obesity</source>. (<year>2017</year>) <volume>25</volume>:<fpage>290</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1002/oby.21720</pub-id><pub-id pub-id-type="pmid">28124507</pub-id></citation></ref>
<ref id="B123">
<label>123.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdelmalek</surname> <given-names>MF</given-names></name> <name><surname>Suzuki</surname> <given-names>A</given-names></name> <name><surname>Guy</surname> <given-names>C</given-names></name> <name><surname>Unalp-Arida</surname> <given-names>A</given-names></name> <name><surname>Colvin</surname> <given-names>R</given-names></name> <name><surname>Johnson</surname> <given-names>RJ</given-names></name> <etal/></person-group>. <article-title>Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease</article-title>. <source>Hepatology.</source> (<year>2010</year>) <volume>51</volume>:<fpage>1961</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1002/hep.23535</pub-id><pub-id pub-id-type="pmid">20301112</pub-id></citation></ref>
<ref id="B124">
<label>124.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname> <given-names>X</given-names></name> <name><surname>Cirillo</surname> <given-names>P</given-names></name> <name><surname>Sautin</surname> <given-names>Y</given-names></name> <name><surname>McCall</surname> <given-names>S</given-names></name> <name><surname>Bruchette</surname> <given-names>JL</given-names></name> <name><surname>Diehl</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Fructose consumption as a risk factor for nonalcoholic fatty liver disease</article-title>. <source>J Hepatol.</source> (<year>2008</year>) <volume>48</volume>:<fpage>993</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2008.02.011</pub-id><pub-id pub-id-type="pmid">18395287</pub-id></citation></ref>
<ref id="B125">
<label>125.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname> <given-names>A</given-names></name> <name><surname>Neil</surname> <given-names>D</given-names></name> <name><surname>Aguila</surname> <given-names>MB</given-names></name> <name><surname>Mandarim-de-Lacerda</surname> <given-names>CA</given-names></name></person-group>. <article-title>Hepatic adverse effects of fructose consumption independent of overweight/obesity</article-title>. <source>Int J Mol Sci.</source> (<year>2013</year>) <volume>14</volume>:<fpage>21873</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.3390/ijms141121873</pub-id><pub-id pub-id-type="pmid">24196354</pub-id></citation></ref>
<ref id="B126">
<label>126.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosca</surname> <given-names>A</given-names></name> <name><surname>Nobili</surname> <given-names>V</given-names></name> <name><surname>De Vito</surname> <given-names>R</given-names></name> <name><surname>Crudele</surname> <given-names>A</given-names></name> <name><surname>Scorletti</surname> <given-names>E</given-names></name> <name><surname>Villani</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Byrne, Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents</article-title>. <source>J Hepatol.</source> (<year>2017</year>) <volume>66</volume>:<fpage>1031</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2016.12.025</pub-id><pub-id pub-id-type="pmid">28214020</pub-id></citation></ref>
<ref id="B127">
<label>127.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname> <given-names>MB</given-names></name> <name><surname>Abrams</surname> <given-names>SH</given-names></name> <name><surname>Barlow</surname> <given-names>SE</given-names></name> <name><surname>Caprio</surname> <given-names>S</given-names></name> <name><surname>Daniels</surname> <given-names>SR</given-names></name> <name><surname>Kohli</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)</article-title>. <source>J Pediatr Gastroenterol Nutr.</source> (<year>2017</year>) <volume>64</volume>:<fpage>319</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0000000000001482</pub-id><pub-id pub-id-type="pmid">28107283</pub-id></citation></ref>
<ref id="B128">
<label>128.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname> <given-names>MB</given-names></name> <name><surname>Weber</surname> <given-names>MB</given-names></name> <name><surname>Welsh</surname> <given-names>J</given-names></name> <name><surname>Khatoon</surname> <given-names>F</given-names></name> <name><surname>Jones</surname> <given-names>DP</given-names></name> <name><surname>Whitington</surname> <given-names>PF</given-names></name> <etal/></person-group>. <article-title>Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study</article-title>. <source>Arch Pediatr Adolesc Med.</source> (<year>2009</year>) <volume>163</volume>:<fpage>674</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1001/archpediatrics.2009.93</pub-id><pub-id pub-id-type="pmid">19581556</pub-id></citation></ref>
<ref id="B129">
<label>129.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>R</given-names></name> <name><surname>Welsh</surname> <given-names>JA</given-names></name> <name><surname>Le</surname> <given-names>NA</given-names></name> <name><surname>Holzberg</surname> <given-names>J</given-names></name> <name><surname>Sharma</surname> <given-names>P</given-names></name> <name><surname>Martin</surname> <given-names>DR</given-names></name> <etal/></person-group>. <article-title>Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD</article-title>. <source>Nutrients.</source> (<year>2014</year>) <volume>6</volume>:<fpage>3187</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.3390/nu6083187</pub-id><pub-id pub-id-type="pmid">25111123</pub-id></citation></ref>
<ref id="B130">
<label>130.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>IS</given-names></name> <name><surname>Ho</surname> <given-names>H</given-names></name> <name><surname>Hoffman</surname> <given-names>BB</given-names></name> <name><surname>Reaven</surname> <given-names>GM</given-names></name></person-group>. <article-title>Fructose-induced insulin resistance and hypertension in rats</article-title>. <source>Hypertension.</source> (<year>1987</year>) <volume>10</volume>:<fpage>512</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.10.5.512</pub-id><pub-id pub-id-type="pmid">3311990</pub-id></citation></ref>
<ref id="B131">
<label>131.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>FJ</given-names></name> <name><surname>Rizza</surname> <given-names>RA</given-names></name> <name><surname>Romero</surname> <given-names>JC</given-names></name></person-group>. <article-title>High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs</article-title>. <source>Hypertension.</source> (<year>1994</year>) <volume>23</volume>:<fpage>456</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.23.4.456</pub-id><pub-id pub-id-type="pmid">8144215</pub-id></citation></ref>
<ref id="B132">
<label>132.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catena</surname> <given-names>C</given-names></name> <name><surname>Giacchetti</surname> <given-names>G</given-names></name> <name><surname>Novello</surname> <given-names>M</given-names></name> <name><surname>Colussi</surname> <given-names>G</given-names></name> <name><surname>Cavarape</surname> <given-names>A</given-names></name> <name><surname>Sechi</surname> <given-names>LA</given-names></name></person-group>. <article-title>Cellular mechanisms of insulin resistance in rats with Fructose-Induced hypertension</article-title>. <source>Am J Hypertension.</source> (<year>2003</year>) <volume>16</volume>(<issue>11 Pt 1</issue>):<fpage>973</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0895-7061(03)01002-1</pub-id><pub-id pub-id-type="pmid">14573337</pub-id></citation></ref>
<ref id="B133">
<label>133.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>KLH</given-names></name> <name><surname>Wu</surname> <given-names>CW</given-names></name> <name><surname>Tain</surname> <given-names>YL</given-names></name> <name><surname>Chao</surname> <given-names>YM</given-names></name> <name><surname>Hung</surname> <given-names>CY</given-names></name> <name><surname>Tsai</surname> <given-names>PC</given-names></name> <etal/></person-group>. <article-title>Effects of high fructose intake on the development of hypertension in the spontaneously hypertensive rats: the role of AT 1 R/gp91 PHOX signaling in the rostral ventrolateral medulla</article-title>. <source>Nutr Biochem.</source> (<year>2017</year>) <volume>41</volume>:<fpage>73</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2016.11.013</pub-id><pub-id pub-id-type="pmid">28063367</pub-id></citation></ref>
<ref id="B134">
<label>134.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname> <given-names>S</given-names></name> <name><surname>Bhanot</surname> <given-names>S</given-names></name> <name><surname>McNeill</surname> <given-names>JH</given-names></name></person-group>. <article-title>Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension</article-title>. <source>Eur J Pharmacol.</source> (<year>1999</year>) <volume>373</volume>:<fpage>R1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-2999(99)00301-5</pub-id><pub-id pub-id-type="pmid">10414447</pub-id></citation></ref>
<ref id="B135">
<label>135.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname> <given-names>K</given-names></name> <name><surname>Hirano</surname> <given-names>T</given-names></name> <name><surname>Ran</surname> <given-names>J</given-names></name> <name><surname>Adachi</surname> <given-names>M</given-names></name></person-group>. <article-title>Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats</article-title>. <source>Hypertens Res.</source> (<year>2004</year>) <volume>27</volume>:<fpage>293</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1291/hypres.27.293</pub-id><pub-id pub-id-type="pmid">15127887</pub-id></citation></ref>
<ref id="B136">
<label>136.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamide</surname> <given-names>K</given-names></name> <name><surname>Rakugi</surname> <given-names>H</given-names></name> <name><surname>Higaki</surname> <given-names>J</given-names></name> <name><surname>Okamura</surname> <given-names>A</given-names></name> <name><surname>Nagai</surname> <given-names>M</given-names></name> <name><surname>Moriguchi</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats</article-title>. <source>Am J Hypertens.</source> (<year>2002</year>) <volume>15</volume>(<issue>1 Pt 1</issue>):<fpage>66</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0895-7061(01)02232-4</pub-id><pub-id pub-id-type="pmid">11824863</pub-id></citation></ref>
<ref id="B137">
<label>137.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>LT</given-names></name> <name><surname>Macleod</surname> <given-names>KM</given-names></name> <name><surname>McNeill</surname> <given-names>JH</given-names></name></person-group>. <article-title>Selective alpha1-adrenoceptor blockade prevents fructose-induced hypertension</article-title>. <source>Mol Cell Biochem.</source> (<year>2014</year>) <volume>392</volume>:<fpage>205</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-014-2031-5</pub-id><pub-id pub-id-type="pmid">24682694</pub-id></citation></ref>
<ref id="B138">
<label>138.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>HH</given-names></name> <name><surname>Chu</surname> <given-names>CH</given-names></name> <name><surname>Wen</surname> <given-names>SW</given-names></name> <name><surname>Lai</surname> <given-names>CC</given-names></name> <name><surname>Cheng</surname> <given-names>PW</given-names></name> <name><surname>Tseng</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Excessive fructose intake impairs baroreflex sensitivity and led to elevated blood pressure in rats</article-title>. <source>Nutrients.</source> (<year>2019</year>) <volume>11</volume>:<fpage>2581</fpage>. <pub-id pub-id-type="doi">10.3390/nu11112581</pub-id><pub-id pub-id-type="pmid">31731536</pub-id></citation></ref>
<ref id="B139">
<label>139.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>CM</given-names></name> <name><surname>Dulloo</surname> <given-names>AG</given-names></name> <name><surname>Yepuri</surname> <given-names>G</given-names></name> <name><surname>Montani</surname> <given-names>JP</given-names></name></person-group>. <article-title>Fructose ingestion acutely elevates blood pressure in healthy young humans</article-title>. <source>Am J Physiol Regul Integr Comp Physiol.</source> (<year>2008</year>) <volume>294</volume>:<fpage>R730</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00680.2007</pub-id><pub-id pub-id-type="pmid">18199590</pub-id></citation></ref>
<ref id="B140">
<label>140.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname> <given-names>EC</given-names></name> <name><surname>de Rooij</surname> <given-names>SR</given-names></name> <name><surname>Oltho</surname> <given-names>MR</given-names></name> <name><surname>Vrijkotte</surname> <given-names>TGM</given-names></name></person-group>. <article-title>Sugar-sweetened beverages intake is associated with blood pressure and sympathetic nervous system activation in children</article-title>. <source>Clin Nutr ESPEN.</source> (<year>2018</year>) <volume>28</volume>:<fpage>232</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnesp.2018.08.020</pub-id><pub-id pub-id-type="pmid">30390887</pub-id></citation></ref>
<ref id="B141">
<label>141.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname> <given-names>JA</given-names></name> <name><surname>Hong</surname> <given-names>E</given-names></name></person-group>. <article-title>A single oral dose of fructose induces some features of metabolic syndrome in rats: role of oxidative stress</article-title>. <source>Nutr Metab Cardiovasc Dis.</source> (<year>2013</year>) <volume>23</volume>:<fpage>536</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2011.10.008</pub-id><pub-id pub-id-type="pmid">22386006</pub-id></citation></ref>
<ref id="B142">
<label>142.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peredo</surname> <given-names>HA</given-names></name> <name><surname>Mayer</surname> <given-names>MA</given-names></name> <name><surname>Fermepin</surname> <given-names>MR</given-names></name> <name><surname>Grinspon</surname> <given-names>D</given-names></name> <name><surname>Puyo</surname> <given-names>AM</given-names></name></person-group>. <article-title>Oral treatment and in vitro incubation with fructose modify vascular prostanoid production in the rat</article-title>. <source>Auton Autacoid Pharmacol.</source> (<year>2006</year>) <volume>26</volume>:<fpage>15</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-8673.2005.00354.x</pub-id><pub-id pub-id-type="pmid">16371062</pub-id></citation></ref>
<ref id="B143">
<label>143.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medeiros</surname> <given-names>RF</given-names></name> <name><surname>Gaique</surname> <given-names>TG</given-names></name> <name><surname>Bento-Bernardes</surname> <given-names>T</given-names></name> <name><surname>Kindlovits</surname> <given-names>R</given-names></name> <name><surname>Gomes</surname> <given-names>TMB</given-names></name> <name><surname>Motta</surname> <given-names>NAV</given-names></name> <etal/></person-group>. <article-title>Arginine and aerobic training prevent endothelial and metabolic alterations in rats at high risk for the development of the metabolic syndrome</article-title>. <source>Br J Nutr.</source> (<year>2017</year>) <volume>118</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114517001702</pub-id><pub-id pub-id-type="pmid">29206092</pub-id></citation></ref>
<ref id="B144">
<label>144.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romanko</surname> <given-names>OP</given-names></name> <name><surname>Ali</surname> <given-names>MI</given-names></name> <name><surname>Mintz</surname> <given-names>JD</given-names></name> <name><surname>Stepp</surname> <given-names>DW</given-names></name></person-group>. <article-title>Insulin resistance impairs endothelial function but not adrenergic reactivity or vascular structure in fructose-fed rats</article-title>. <source>Microcirculation.</source> (<year>2009</year>) <volume>16</volume>:<fpage>414</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1080/10739680902832795</pub-id><pub-id pub-id-type="pmid">19382001</pub-id></citation></ref>
<ref id="B145">
<label>145.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Genovesi</surname> <given-names>S</given-names></name> <name><surname>Giussani</surname> <given-names>M</given-names></name> <name><surname>Orlando</surname> <given-names>A</given-names></name> <name><surname>Lieti</surname> <given-names>G</given-names></name> <name><surname>Viazzi</surname> <given-names>F</given-names></name> <name><surname>Parati</surname> <given-names>G</given-names></name></person-group>. <article-title>Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescents</article-title>. <source>Pediatr Nephrol.</source> (<year>2021</year>) <volume>37</volume>:<fpage>537</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-021-05144-2</pub-id><pub-id pub-id-type="pmid">34085102</pub-id></citation></ref>
<ref id="B146">
<label>146.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Farias Lelis</surname> <given-names>D</given-names></name> <name><surname>Andrade</surname> <given-names>JMO</given-names></name> <name><surname>Almenara</surname> <given-names>CCP</given-names></name> <name><surname>Broseguini-Filho</surname> <given-names>GB</given-names></name> <name><surname>Mill</surname> <given-names>JG</given-names></name> <name><surname>Baldo</surname> <given-names>MP</given-names></name></person-group>. <article-title>High fructose intake and the route towards cardiometabolic diseases</article-title>. <source>Life Sciences.</source> (<year>2020</year>) <volume>259</volume>:<fpage>118235</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.118235</pub-id><pub-id pub-id-type="pmid">32800834</pub-id></citation></ref>
<ref id="B147">
<label>147.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname> <given-names>S</given-names></name> <name><surname>Palmer</surname> <given-names>RM</given-names></name> <name><surname>Higgs</surname> <given-names>EA</given-names></name></person-group>. <article-title>Nitric oxide: physiology, pathophysiology, and pharmacology</article-title>. <source>Pharmacol Rev.</source> (<year>1991</year>) <volume>43</volume>:<fpage>109</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="pmid">1852778</pub-id></citation></ref>
<ref id="B148">
<label>148.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Bassossy</surname> <given-names>HM</given-names></name> <name><surname>Dsokey</surname> <given-names>N</given-names></name> <name><surname>Fahmy</surname> <given-names>A</given-names></name></person-group>. <article-title>Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome</article-title>. <source>Toxicol Mech Methods.</source> (<year>2014</year>) <volume>24</volume>:<fpage>536</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.3109/15376516.2014.945109</pub-id><pub-id pub-id-type="pmid">25046175</pub-id></citation></ref>
<ref id="B149">
<label>149.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinozaki</surname> <given-names>K</given-names></name> <name><surname>Ayajiki</surname> <given-names>K</given-names></name> <name><surname>Nishio</surname> <given-names>Y</given-names></name> <name><surname>Sugaya</surname> <given-names>T</given-names></name> <name><surname>Kashiwagi</surname> <given-names>A</given-names></name> <name><surname>Okamura</surname> <given-names>T</given-names></name></person-group>. <article-title>Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance</article-title>. <source>Hypertension.</source> (<year>2004</year>) <volume>43</volume>:<fpage>255</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000111136.86976.26</pub-id><pub-id pub-id-type="pmid">14698997</pub-id></citation></ref>
<ref id="B150">
<label>150.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname> <given-names>T</given-names></name> <name><surname>Tawa</surname> <given-names>M</given-names></name> <name><surname>Geddawy</surname> <given-names>A</given-names></name> <name><surname>Shimosato</surname> <given-names>T</given-names></name> <name><surname>Iwasaki</surname> <given-names>H</given-names></name> <name><surname>Shintaku</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats</article-title>. <source>J Pharmacol Sci.</source> (<year>2014</year>) <volume>124</volume>:<fpage>76</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.13178FP</pub-id><pub-id pub-id-type="pmid">24389820</pub-id></citation></ref>
<ref id="B151">
<label>151.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malakul</surname> <given-names>W</given-names></name> <name><surname>Pengnet</surname> <given-names>S</given-names></name> <name><surname>Kumchoom</surname> <given-names>C</given-names></name> <name><surname>Tunsophon</surname> <given-names>S</given-names></name></person-group>. <article-title>Naringin ameliorates endothelial dysfunction in fructose-fed rats</article-title>. <source>Exp Ther Med.</source> (<year>2018</year>) <volume>15</volume>:<fpage>3140</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2018.5759</pub-id><pub-id pub-id-type="pmid">29456717</pub-id></citation></ref>
<ref id="B152">
<label>152.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miatello</surname> <given-names>R</given-names></name> <name><surname>Risler</surname> <given-names>N</given-names></name> <name><surname>Castro</surname> <given-names>C</given-names></name> <name><surname>Gonz&#x000E1;lez</surname> <given-names>S</given-names></name> <name><surname>R&#x000FC;ttler</surname> <given-names>M</given-names></name> <name><surname>Cruzado</surname> <given-names>M</given-names></name></person-group>. <article-title>Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats</article-title>. <source>Am J Hypertens.</source> (<year>2001</year>) <volume>14</volume>(<issue>11 Pt 1</issue>):<fpage>1135</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0895-7061(01)02206-3</pub-id><pub-id pub-id-type="pmid">11724213</pub-id></citation></ref>
<ref id="B153">
<label>153.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>P</given-names></name></person-group>. <article-title>Attenuation of insulin-mediated pressor effect and nitric oxide release in rats with fructose-induced insulin resistance</article-title>. <source>Am J Hypertens.</source> (<year>2004</year>) <volume>17</volume>:<fpage>707</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjhyper.2004.04.006</pub-id><pub-id pub-id-type="pmid">15323066</pub-id></citation></ref>
<ref id="B154">
<label>154.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juan</surname> <given-names>C</given-names></name> <name><surname>Fang</surname> <given-names>VS</given-names></name> <name><surname>Hsu</surname> <given-names>Y</given-names></name> <name><surname>Huang</surname> <given-names>Y</given-names></name> <name><surname>Hsia</surname> <given-names>D</given-names></name> <name><surname>Yu</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose induced hypertensive rat model</article-title>. <source>J Hypertens.</source> (<year>1998</year>) <volume>116</volume>(<issue>12 Pt 1</issue>):<fpage>1775</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1097/00004872-199816120-00010</pub-id><pub-id pub-id-type="pmid">9869011</pub-id></citation></ref>
<ref id="B155">
<label>155.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdulla</surname> <given-names>MH</given-names></name> <name><surname>Sattar</surname> <given-names>MA</given-names></name> <name><surname>Johns</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Effects of tempol on altered metabolism and renal vascular responsiveness in fructose-fed rats</article-title>. <source>Appl Physiol Nutr Metab.</source> (<year>2015</year>) <volume>41</volume>:<fpage>210</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1139/apnm-2015-0411</pub-id><pub-id pub-id-type="pmid">26789093</pub-id></citation></ref>
<ref id="B156">
<label>156.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdelrahman</surname> <given-names>AM</given-names></name> <name><surname>Al Suleimani</surname> <given-names>YM</given-names></name> <name><surname>Ashique</surname> <given-names>M</given-names></name> <name><surname>Manoj</surname> <given-names>P</given-names></name> <name><surname>Ali</surname> <given-names>BH</given-names></name></person-group>. <article-title>Effect of infliximab and tocilizumab on fructose-induced hyperinsulinemia and hypertension in rats</article-title>. <source>Biomed Pharmacother.</source> (<year>2018</year>) <volume>105</volume>:<fpage>182</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.05.118</pub-id><pub-id pub-id-type="pmid">29857297</pub-id></citation></ref>
<ref id="B157">
<label>157.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sivaraman</surname> <given-names>K</given-names></name> <name><surname>Senthilkumar</surname> <given-names>GP</given-names></name> <name><surname>Sankar</surname> <given-names>P</given-names></name> <name><surname>Bobby</surname> <given-names>Z</given-names></name></person-group>. <article-title>Attenuation of oxidative stress, inflammation and insulin resistance by Allium sativum in fructose&#x02013;fed male rats</article-title>. <source>J Clin Diagn Res.</source> (<year>2013</year>) <volume>7</volume>:<fpage>1860</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.7860/JCDR/2013/6924.3334</pub-id><pub-id pub-id-type="pmid">24179882</pub-id></citation></ref>
<ref id="B158">
<label>158.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniyama</surname> <given-names>Y</given-names></name> <name><surname>Griendling</surname> <given-names>KK</given-names></name></person-group>. <article-title>Reactive oxygen species in the vasculature: molecular and cellular mechanisms</article-title>. <source>Hypertension.</source> (<year>2003</year>) <volume>42</volume>:<fpage>1075</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000100443.09293.4F</pub-id><pub-id pub-id-type="pmid">14581295</pub-id></citation></ref>
<ref id="B159">
<label>159.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayalath</surname> <given-names>VH</given-names></name> <name><surname>de Souza</surname> <given-names>RJ</given-names></name> <name><surname>Ha</surname> <given-names>V</given-names></name> <name><surname>Mirrahimi</surname> <given-names>A</given-names></name> <name><surname>Blanco-Mejia</surname> <given-names>S</given-names></name> <name><surname>Di Buono</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts</article-title>. <source>Am J Clin Nutr.</source> (<year>2015</year>) <volume>102</volume>:<fpage>914</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.115.107243</pub-id><pub-id pub-id-type="pmid">26269365</pub-id></citation></ref>
<ref id="B160">
<label>160.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>AH</given-names></name> <name><surname>Akram</surname> <given-names>Y</given-names></name> <name><surname>Shetty</surname> <given-names>S</given-names></name> <name><surname>Malik</surname> <given-names>SS</given-names></name> <name><surname>Yanchou Njike</surname> <given-names>VY</given-names></name></person-group>. <article-title>Impact of sugar-sweetened beverages on blood pressure</article-title>. <source>Am J Cardiol.</source> (<year>2014</year>) <volume>113</volume>:<fpage>1574</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2014.01.437</pub-id><pub-id pub-id-type="pmid">24630785</pub-id></citation></ref>
<ref id="B161">
<label>161.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farhangi</surname> <given-names>MA</given-names></name> <name><surname>Nikniaz</surname> <given-names>L</given-names></name> <name><surname>Khodarahmi</surname> <given-names>M</given-names></name></person-group>. <article-title>Sugar-sweetened beverages increases the risk of hypertension among children and adolescence: a systematic review and dose&#x02013;response meta-analysis</article-title>. <source>J Transl Med.</source> (<year>2020</year>) <volume>18</volume>:<fpage>344</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-020-02511-9</pub-id><pub-id pub-id-type="pmid">32891165</pub-id></citation></ref>
<ref id="B162">
<label>162.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>S</given-names></name> <name><surname>Da</surname> <given-names>M</given-names></name> <name><surname>Choi</surname> <given-names>HK</given-names></name> <name><surname>Lustig</surname> <given-names>RH</given-names></name> <name><surname>Hsu</surname> <given-names>C</given-names></name></person-group>. <article-title>Sugar sweetened beverages, serum uric acid, and blood pressure in adolescents</article-title>. <source>Pediatr.</source> (<year>2009</year>) <volume>154</volume>:<fpage>807</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2009.01.015</pub-id><pub-id pub-id-type="pmid">19375714</pub-id></citation></ref>
<ref id="B163">
<label>163.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>Z</given-names></name> <name><surname>Xu</surname> <given-names>F</given-names></name> <name><surname>Ye</surname> <given-names>Q</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>He</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Sugar-sweetened beverages and school students&#x00027; hypertension in urban areas of Nanjing, China</article-title>. <source>J Hum Hypertens.</source> (<year>2018</year>) <volume>32</volume>:<fpage>392</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/s41371-018-0030-9</pub-id><pub-id pub-id-type="pmid">29410454</pub-id></citation></ref>
<ref id="B164">
<label>164.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname> <given-names>BSN</given-names></name> <name><surname>Cunhaa</surname> <given-names>DB</given-names></name> <name><surname>Rosangela</surname> <given-names>A</given-names></name> <name><surname>Pereirab</surname> <given-names>RA</given-names></name> <name><surname>Sichieri</surname> <given-names>R</given-names></name></person-group>. <article-title>Soft drink consumption, mainly diet ones, is associated with increased blood pressure in adolescents</article-title>. <source>J Hypertens.</source> (<year>2016</year>) <volume>34</volume>:<fpage>221</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/HJH.0000000000000800</pub-id><pub-id pub-id-type="pmid">26682780</pub-id></citation></ref>
<ref id="B165">
<label>165.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>WT</given-names></name> <name><surname>Huang</surname> <given-names>HL</given-names></name> <name><surname>Huang</surname> <given-names>MC</given-names></name> <name><surname>Chan</surname> <given-names>TF</given-names></name> <name><surname>Ciou</surname> <given-names>SY</given-names></name> <name><surname>Lee</surname> <given-names>CY</given-names></name> <etal/></person-group>. <article-title>Effects on uric acid, body mass index and blood pressure in adolescents of consuming beverages sweetened with high-fructose corn syrup</article-title>. <source>Int J Obes.</source> (<year>2013</year>) <volume>37</volume>:<fpage>532</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2012.121</pub-id><pub-id pub-id-type="pmid">22890489</pub-id></citation></ref>
<ref id="B166">
<label>166.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname> <given-names>ZH</given-names></name> <name><surname>Zhu</surname> <given-names>YN</given-names></name> <name><surname>Cai</surname> <given-names>L</given-names></name> <name><surname>Sun</surname> <given-names>FH</given-names></name> <name><surname>Ma</surname> <given-names>YH</given-names></name> <name><surname>Jing</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Sugar-sweetened beverage consumption and risks of obesity and hypertension in Chinese children and adolescents: a national cross-sectional analysis</article-title>. <source>Nutrients.</source> (<year>2017</year>) <volume>9</volume>:<fpage>1302</fpage>. <pub-id pub-id-type="doi">10.3390/nu9121302</pub-id><pub-id pub-id-type="pmid">29189729</pub-id></citation></ref>
<ref id="B167">
<label>167.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Z</given-names></name> <name><surname>He</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>He</surname> <given-names>X</given-names></name> <name><surname>Zang</surname> <given-names>J</given-names></name> <name><surname>Guo</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>The associations between sugar-sweetened beverage intake and cardiometabolic risks in Chinese children and adolescents</article-title>. <source>Pediatr Obes.</source> (<year>2020</year>) <volume>15</volume>:<fpage>e12634</fpage>. <pub-id pub-id-type="doi">10.1111/ijpo.12634</pub-id><pub-id pub-id-type="pmid">32196990</pub-id></citation></ref>
<ref id="B168">
<label>168.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asghari</surname> <given-names>G</given-names></name> <name><surname>Yuzbashian</surname> <given-names>E</given-names></name> <name><surname>Mirmiran</surname> <given-names>P</given-names></name> <name><surname>Bahadoran</surname> <given-names>Z</given-names></name> <name><surname>Azizi</surname> <given-names>F</given-names></name></person-group>. <article-title>Prediction of metabolic syndrome by a high intake of energy-dense nutrient-poor snacks in Iranian children and adolescents</article-title>. <source>Pediatr Res.</source> (<year>2016</year>) <volume>79</volume>:<fpage>697</fpage>&#x02013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2015.270</pub-id><pub-id pub-id-type="pmid">26717004</pub-id></citation></ref>
<ref id="B169">
<label>169.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>FJ</given-names></name> <name><surname>Marrero</surname> <given-names>NM</given-names></name> <name><surname>MacGregor</surname> <given-names>GA</given-names></name></person-group>. <article-title>Salt intake is related to soft drink consumption in children and adolescents: a link to obesity?</article-title> <source>Hypertension.</source> (<year>2008</year>) <volume>51</volume>:<fpage>629</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.100990</pub-id><pub-id pub-id-type="pmid">18499562</pub-id></citation></ref>
<ref id="B170">
<label>170.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perng</surname> <given-names>W</given-names></name> <name><surname>Tang</surname> <given-names>L</given-names></name> <name><surname>Song</surname> <given-names>PXK</given-names></name> <name><surname>Goran</surname> <given-names>M</given-names></name> <name><surname>Rojo</surname> <given-names>MMT</given-names></name> <name><surname>Cantoral A et</surname> <given-names>al</given-names></name></person-group>. <article-title>Urate and nonanoate mark the relationship between sugar-sweetened beverage intake and blood pressure in adolescent girls: a metabolomics analysis in the ELEMENT cohort</article-title>. <source>Metabolites.</source> (<year>2019</year>) <volume>9</volume>:<fpage>100</fpage>. <pub-id pub-id-type="doi">10.3390/metabo9050100</pub-id><pub-id pub-id-type="pmid">31108933</pub-id></citation></ref>
<ref id="B171">
<label>171.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tipton</surname> <given-names>JA</given-names></name></person-group>. <article-title>Reducing sugar-sweetened beverage intake among students: school-based programs and policies that work</article-title>. <source>NASN Sch Nurse</source>. (<year>2016</year>) <volume>31</volume>:<fpage>102</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1177/1942602X15578456</pub-id><pub-id pub-id-type="pmid">25816431</pub-id></citation></ref>
<ref id="B172">
<label>172.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veugelers</surname> <given-names>PJ</given-names></name> <name><surname>Fitzgerald</surname> <given-names>AL</given-names></name></person-group>. <article-title>Effectiveness of school programs in preventing childhood obesity: a multilevel comparison</article-title>. <source>Am J Public Health</source>. (<year>2005</year>) <volume>95</volume>:<fpage>432</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2004.045898</pub-id><pub-id pub-id-type="pmid">15727972</pub-id></citation></ref>
<ref id="B173">
<label>173.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>TL</given-names></name> <name><surname>Karen</surname> <given-names>BF</given-names></name> <name><surname>Wang</surname> <given-names>YC</given-names></name></person-group>. <article-title>A review of the literature on policies directed at the youth consumption of sugar sweetened beverages. American society for nutrition</article-title>. <source>Adv Nutr</source>. (<year>2011</year>) <volume>2</volume>:<fpage>182S</fpage>&#x02212;<lpage>200S</lpage>. <pub-id pub-id-type="doi">10.3945/an.111.000356</pub-id><pub-id pub-id-type="pmid">22332051</pub-id></citation></ref>
<ref id="B174">
<label>174.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Ruyter</surname> <given-names>JC</given-names></name> <name><surname>Olthof</surname> <given-names>MR</given-names></name> <name><surname>Seidell</surname> <given-names>JC</given-names></name> <name><surname>Martijn</surname> <given-names>B</given-names></name></person-group>. <article-title>A trial of sugar-free or sugar-sweetened beverages body weight in children</article-title>. <source>Katan N Engl J Med.</source> (<year>2012</year>) <volume>367</volume>:<fpage>1397</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1203034</pub-id><pub-id pub-id-type="pmid">27447721</pub-id></citation></ref>
<ref id="B175">
<label>175.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>James</surname> <given-names>J</given-names></name> <name><surname>Thomas</surname> <given-names>P</given-names></name> <name><surname>Cavan</surname> <given-names>D</given-names></name> <name><surname>Kerr</surname> <given-names>D</given-names></name></person-group>. <article-title>Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial</article-title>. <source>BMJ</source>. (<year>2004</year>) <volume>328</volume>:<fpage>1237</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.38077.458438.EE</pub-id><pub-id pub-id-type="pmid">15107313</pub-id></citation></ref>
<ref id="B176">
<label>176.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ebbeling</surname> <given-names>CB</given-names></name> <name><surname>Feldman</surname> <given-names>HA</given-names></name> <name><surname>Osganian</surname> <given-names>SK</given-names></name> <name><surname>Chomitz</surname> <given-names>VR</given-names></name> <name><surname>Ellenbogen</surname> <given-names>SJ</given-names></name> <name><surname>Ludwig</surname> <given-names>DS</given-names></name></person-group>. <article-title>Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study</article-title>. <source>Pediatrics</source>. (<year>2006</year>) <volume>117</volume>:<fpage>673</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="pmid">16510646</pub-id></citation></ref>
<ref id="B177">
<label>177.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname> <given-names>R</given-names></name> <name><surname>Ooi</surname> <given-names>JY</given-names></name> <name><surname>Finch</surname> <given-names>M</given-names></name> <name><surname>Yoong</surname> <given-names>SL</given-names></name> <name><surname>Nathan</surname> <given-names>N</given-names></name> <name><surname>Wrigley</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>A cluster randomised controlled trial of a secondary school intervention to reduce intake of sugar-sweetened beverages: mid-intervention impact of switchURsip environmental strategies</article-title>. <source>Health Promot J Austral</source>. (<year>2021</year>) <volume>33</volume>:<fpage>176</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1002/hpja.469</pub-id><pub-id pub-id-type="pmid">33577117</pub-id></citation></ref>
<ref id="B178">
<label>178.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ebbeling</surname> <given-names>CB</given-names></name> <name><surname>Feldman</surname> <given-names>HA</given-names></name> <name><surname>Chomitz</surname> <given-names>VR</given-names></name> <name><surname>Antonelli</surname> <given-names>TA</given-names></name> <name><surname>Gortmaker</surname> <given-names>SL</given-names></name> <name><surname>Osganian</surname> <given-names>SK</given-names></name> <etal/></person-group>. <article-title>A randomized trial of sugar-sweetened beverages adolescent body weight</article-title>. <source>N Engl J Med.</source> (<year>2012</year>) <volume>367</volume>:<fpage>1407</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1203388</pub-id><pub-id pub-id-type="pmid">22998339</pub-id></citation></ref>
<ref id="B179">
<label>179.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>FB</given-names></name></person-group>. <article-title>Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases</article-title>. <source>Obes Rev</source>. (<year>2013</year>) <volume>14</volume>:<fpage>606</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/obr.12040</pub-id><pub-id pub-id-type="pmid">23763695</pub-id></citation></ref>
<ref id="B180">
<label>180.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brownell</surname> <given-names>KD</given-names></name> <name><surname>Farley</surname> <given-names>T</given-names></name> <name><surname>Willett</surname> <given-names>WC</given-names></name></person-group>. <article-title>The public health and economic benefits of taxing sugar-sweetened beverages</article-title>. <source>N Engl J Med.</source> (<year>2009</year>) <volume>361</volume>:<fpage>1599</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMhpr0905723</pub-id><pub-id pub-id-type="pmid">19759377</pub-id></citation></ref>
<ref id="B181">
<label>181.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>YC</given-names></name> <name><surname>Bleich</surname> <given-names>SN</given-names></name> <name><surname>Gortmaker</surname> <given-names>SL</given-names></name></person-group>. <article-title>Increasing caloric contribution from sugar-sweetened beverages and 100% fruit juices among US children and adolescents, 1988&#x02013;2004</article-title>. <source>Pediatrics.</source> (<year>2008</year>) <volume>121</volume>:<fpage>e1604</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2007-2834</pub-id><pub-id pub-id-type="pmid">18519465</pub-id></citation></ref>
<ref id="B182">
<label>182.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Busey</surname> <given-names>E</given-names></name></person-group>. <source>Sugary Drink Taxes Around the World</source>. <publisher-loc>Chapel Hill, NC</publisher-loc>: <publisher-name>Carolina Population Center</publisher-name> (<year>2020</year>). <pub-id pub-id-type="pmid">32928228</pub-id></citation></ref>
<ref id="B183">
<label>183.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chriqui</surname> <given-names>JF</given-names></name> <name><surname>Eidson</surname> <given-names>SS</given-names></name> <name><surname>Bates</surname> <given-names>H</given-names></name> <name><surname>Kowalczyk</surname> <given-names>S</given-names></name> <name><surname>Chaloupka</surname> <given-names>FJ</given-names></name></person-group>. <article-title>State sales tax rates for soft drinks and snacks sold through grocery stores and vending machines, 2007</article-title>. <source>J Public Health Policy.</source> (<year>2008</year>) <volume>29</volume>:<fpage>226</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1057/jphp.2008.9</pub-id><pub-id pub-id-type="pmid">18523476</pub-id></citation></ref>
<ref id="B184">
<label>184.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brownell</surname> <given-names>KD</given-names></name> <name><surname>Farley</surname> <given-names>T</given-names></name> <name><surname>Willett</surname> <given-names>WC</given-names></name> <name><surname>Popkin</surname> <given-names>BM</given-names></name> <name><surname>Chaloupka</surname> <given-names>FJ</given-names></name> <name><surname>Thompson</surname> <given-names>JW</given-names></name></person-group>. <article-title>The public health and economic benefits of taxing sugar-sweetened beverages</article-title>. <source>N Engl J Med</source>. (<year>2009</year>) <volume>361</volume>:<fpage>1599</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="pmid">19759377</pub-id></citation></ref>
<ref id="B185">
<label>185.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buhler</surname> <given-names>S</given-names></name> <name><surname>Raine</surname> <given-names>KD</given-names></name> <name><surname>Arango</surname> <given-names>M</given-names></name> <name><surname>Pellerin</surname> <given-names>S</given-names></name> <name><surname>Neary</surname> <given-names>NE</given-names></name></person-group>. <article-title>Building a strategy for obesity prevention one piece at a time: the case of sugar- sweetened beverage taxation</article-title>. <source>Can J Diabetes</source>. (<year>2013</year>) <volume>37</volume>:<fpage>97</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcjd.2013.03.025</pub-id><pub-id pub-id-type="pmid">24070799</pub-id></citation></ref>
<ref id="B186">
<label>186.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>LM</given-names></name> <name><surname>Chriqui</surname> <given-names>J</given-names></name> <name><surname>Chaloupka</surname> <given-names>FJ</given-names></name></person-group>. <article-title>Powell, Associations between state-level soda taxes adolescent body mass index</article-title>. <source>J Adolesc Health</source>. (<year>2009</year>) <volume>45</volume>(3 Suppl):<fpage>S57</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.jadohealth.2009.03.003</pub-id><pub-id pub-id-type="pmid">19699437</pub-id></citation></ref>
<ref id="B187">
<label>187.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname> <given-names>R</given-names></name> <name><surname>Powell</surname> <given-names>LM</given-names></name> <name><surname>Chriqui</surname> <given-names>JF</given-names></name> <name><surname>Chaloupka</surname> <given-names>FJ</given-names></name></person-group>. <article-title>Soda taxes, soft drink consumption, and children&#x00027;s body mass index</article-title>. <source>Health Aff (Millwood).</source> (<year>2010</year>) <volume>29</volume>:<fpage>1052</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1377/hlthaff.2009.0061</pub-id><pub-id pub-id-type="pmid">20360173</pub-id></citation></ref>
<ref id="B188">
<label>188.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname> <given-names>J</given-names></name> <name><surname>Frisvold</surname> <given-names>D</given-names></name> <name><surname>Tefft</surname> <given-names>N</given-names></name></person-group>. <article-title>The effects of soft drink taxes on child and adolescent consumption and weight outcomes</article-title>. <source>J Public Econ.</source> (<year>2010</year>) <volume>2010</volume>:<fpage>967</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpubeco.2010.09.005</pub-id><pub-id pub-id-type="pmid">21940223</pub-id></citation></ref>
<ref id="B189">
<label>189.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edmondson</surname> <given-names>EK</given-names></name></person-group>. <article-title>Association of a sweetened beverage tax with soda consumption in high school students</article-title>. <source>JAMA Pediatr.</source> (<year>2021</year>) <volume>175</volume>:<fpage>1261</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2021.3991</pub-id><pub-id pub-id-type="pmid">34661612</pub-id></citation></ref>
<ref id="B190">
<label>190.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gra&#x0010D;ner</surname> <given-names>T</given-names></name> <name><surname>Marquez-Padilla</surname> <given-names>F</given-names></name> <name><surname>Hernandez-Cortes</surname> <given-names>D</given-names></name></person-group>. <article-title>Changes in weight-related outcomes among adolescents following consumer price increases of taxed sugar-sweetened beverages</article-title>. <source>JAMA Pediatr.</source> (<year>2021</year>) <volume>176</volume>:<fpage>150</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2021.5044</pub-id><pub-id pub-id-type="pmid">34902003</pub-id></citation></ref>
<ref id="B191">
<label>191.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krukowski</surname> <given-names>CN</given-names></name> <name><surname>Conley</surname> <given-names>KM</given-names></name> <name><surname>Sterling</surname> <given-names>M</given-names></name> <name><surname>Rainville</surname> <given-names>AJ</given-names></name></person-group>. <article-title>A qualitative study of adolescent views of sugar-sweetened beverage Taxes, Michigan, 2014</article-title>. <source>Prev Chronic Dis.</source> (<year>2016</year>) <volume>13</volume>:<fpage>E60</fpage>. <pub-id pub-id-type="doi">10.5888/pcd13.150543</pub-id><pub-id pub-id-type="pmid">27149071</pub-id></citation></ref>
</ref-list> 
</back>
</article> 
